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SUMMARY 
 
 Major technical challenges remain before enabling complete functional recovery 
after a severe nerve injury.  Creating a growth permissive environment and directing the 
extension and myelination of surviving neurons encompass the current goals of nerve 
regeneration strategies.  A potential solution to address these challenges is to promote 
neurite sprouting and guide the regenerating nerve using biomaterials.  We hypothesize 
that neurite sprouting and extension can be enhanced by using biomaterials as a platform 
to present biochemical and physical cues.  We present a series of biodegradable polymers 
with varying concentrations of acetylcholine-like motifs and a scaffold fabrication 
method for producing porous scaffolds containing longitudinally oriented channels. 
 Acetylcholine is a neurotransmitter involved in neuronal processes, which 
regulates neurite branching, induces neurite outgrowth, and promotes the formation of 
synapses.  Because of its various roles in neuronal activities, acetylcholine-based 
materials may also be useful in nerve repair.  Acetylcholine-like motifs were incorporated 
within a polymer by the polycondensation of diglycidyl sebacate, aminoethyl acetate, and 
leucine ethyl ester, in a manner that permitted control over acetylcholine motif 
concentration.  Diglycidyl sebacate was synthesized by oxidation of diallyl sebacate, 
while the amine-containing compounds, aminoethyl acetate and leucine ethyl ester, were 
liberated with sodium carbonate-sodium bicarbonate buffers.  Standard analytical 
techniques were used to quantify acetylcholine motif concentrations, as well as to 
characterize molecular weights and glass transition temperatures of the polymers.  The 
modular design of synthesizing the polymers can be used to test the effects of presenting 
xiii 
different neurotransmitter motifs, a combination of two or more neurotransmitter motifs, 
or polymer backbones on neurite sprouting in future studies.   
Interactions between the polymers of different acetylcholine motif concentrations 
and neurons were characterized using rat dorsal root ganglia explants (DRG).  We 
screened the potential application of these materials in nerve tissue engineering using the 
following criteria: 1) neurite sprouting, 2) neurite length, and 3) distribution of the neurite 
lengths.  The ability of DRG to sprout neurites was influenced by the concentration of 
acetylcholine motifs of the polymer.  All polymers permitted neurite extension and 
maintained the neuronal phenotype.  Addition of acetylcholine receptor antagonists to 
DRG cultured on the polymers significantly decreased neurite sprouting, suggesting 
acetylcholine receptors mediate sprouting on the polymers.  Future studies may examine 
how neurons on acetylcholine-based polymers exhibit changes in downstream signaling 
events and cell excitability that are associated with receptor activation.   
In preparation for testing the acetylcholine-based polymers in vivo, porous 
scaffolds with longitudinally oriented channels were fabricated using fiber templating and 
salt leaching.  Scaffolds were made of poly(glycerol sebacate) because of this polymer’s 
comparable mechanical properties to the peripheral nerve and its biocompatibility in 
nerve regeneration applications.  Micro computed tomography, scanning electron 
microscopy, and cryo-sectioning revealed the presence of longitudinally oriented 
channels going along the length of the scaffold.  Channel volume and average pore size 
of the scaffolds were controlled by the number of fibers and salt fusion time.  Future 
studies may involve testing the effect of acetylcholine-motifs by coating polymers onto 
xiv 
such scaffolds or assessing the effect of the scaffold’s dimensional properties on nerve 
regeneration. 
1 
Chapter 1. INTRODUCTION 
 
1.1 Statement of Problem 
Resolving challenges in nerve regeneration will significantly improve the quality 
of life for millions of individuals and considerably reduce socioeconomic costs associated 
with such injuries.  Nerve injuries are caused by violence, motor vehicle accidents, or 
sports injury, leading to compression, extension, laceration, or penetration of the nerve.  
Peripheral nerve damage can lead to sensory loss and neuropathic pain, while spinal cord 
injury is the most debilitating type of nerve injury.  The gold standard for treating large 
peripheral nerve gaps (> 3 cm) is by using a sensory nerve isolated from another site as 
an autograft, a treatment that has several drawbacks.  Autograft use is associated with 
morbidity at the donor site, potential mismatch in the dimensions of the nerve being 
replaced, and does not preclude neuropathic pain after nerve regeneration1.     
In contrast to the ability to treat peripheral nerve injury, there is no current 
treatment capable of completely restoring functions after spinal cord injury.  Spinal cord 
injury can have very disruptive physical and economic effects on the affected individuals.  
In the U.S. alone, it is estimated that 11,000 individuals sustain spinal cord injury each 
year, while more than 250,000 are already affected2.  Difficulties include respiratory 
complications, arrhythmias, blood clots, bladder and bowel problems, and reduced 
reproductive functions2,3.  Immense costs are associated with current health care and the 
inability to work after sustaining such nerve injuries.  Patient care is estimated to cost 
more than $4 billion annually in the U.S., a figure that does not include an additional $2.6 
billion dollars that is attributed to loss of productivity due to injury4.     
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1.2 Addressing Challenges in Nerve Repair Using Biomaterials  
The major technical challenges for regenerating the nerve include creating a 
growth permissive environment and directing the extension and myelination of surviving 
and regenerating neurons.  Until such challenges are addressed, there will continue to be 
limited treatments that restore complete function following severe nerve injury5.  Axons 
in the central nervous system have a poor regenerative response compared to peripheral 
nerves and the fundamental reasons for this difference are unresolved.  The ability to 
regenerate even a small fraction of the damaged spinal cord in animal models has led to 
disproportionate returns on neurological function6.  In treating peripheral nerve injury, 
the isolation of a nerve autograft leads to permanent sacrifice of the functional nerve.  A 
disparity in autograft dimensions with the injured nerve is an additional limitation which 
may be addressed by developing alternative approaches that will replace autograft use.  A 
potential solution to address these challenges is to promote neurite sprouting and guide 
the regenerating nerve using biomaterials7.  Biomaterials may provide a physical 
construct to reconnect the severed nerve by serving as a guidance channel, be seeded with 
the relevant cells to encourage growth as a scaffold, encapsulate growth factors as a 
delivery vehicle, modulate cells’ electrical excitability, or function as a combination of 
these. 
 
1.3  Hypothesis and Objectives 
Our central hypothesis is that neurite sprouting and extension can be 
enhanced by using biomaterials as a platform to present biochemical and physical 
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cues.  The objective is to control the presentation of biochemical and physical cues in 
order to test the hypothesis.  
Neurotransmitters play an important role in neural cell activities, and the direct 
integration of neurotransmitter motifs may be an alternative to impart bioactivity to 
synthetic polymers.  Neurotransmitters influence neurite branching in embryonic and 
adult neurons8,9, growth-cone turning10, and may be involved in synapse formation11,12.  
Integration of dopamine into a biodegradable polymer has been shown to influence cell 
differentiation and neurite sprouting13.  We hypothesize that biodegradable materials 
containing neurotransmitter-like motifs promote neurite extension.   
In addition to biochemical cues, physical cues presented through topographical 
features can provide guidance to a variety of cells, including mesenchymal cells, 
oligodendrocytes, neurons, and macrophages14.  The growth cone is thought to be 
involved in causing navigational responses, as axonal extension proceeds through this 
sensing process.  The substrate’s adhesiveness15 and shape16,17 affects growth cone 
motility, while pattern dimensions also influence the alignment and length of neurons18-
20.  There is increasing research aimed at identifying effective approaches for directing 
neurite growth.  The effects of contact guidance on directing neurite orientation has been 
investigated through the use of aligned channels21-26, fibers 27-31, and in surface patterning 
techniques18,32-35.  Because topographical cues play a role in guiding neurite sprouting, 
we sought to create a micro-porous scaffold containing longitudinal channels with 
controllable characteristics. 
The following specific aims are designed to accomplish the objective and test the 
central hypothesis: 
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1. Synthesis of new polymers based on a modular design that enables control of 
the polymer backbone and the concentration of the acetylcholine-like motif. 
2. In vitro assessment of neurite sprouting on polymers that contain varying 
amounts of acetylcholine-like motif. 
3. Fabrication of porous scaffolds containing longitudinal channels with 
controllable properties using salt leaching and fiber templating.   
 
1.4 Nervous System Biology and Responses to Injury 
1.4.1 Components and Organization of the Peripheral and Central Nervous 
System 
By understanding the organization and the biology of the nervous system, specific 
strategies may be developed to overcome the particular challenges associated with 
peripheral and central nerve repair.  The peripheral nervous system (PNS) includes 
cranial, spinal, and sensory nerves emanating from the brain, from the spinal cord, and to 
the extremities, respectively.  The brain and spinal cord comprise the central nervous 
system (CNS).  The main functional cell of both the CNS and PNS is the neuron.  A 
neuron forms specific contacts (synapses) with other neurons via processes called axons 
and dendrites to create networks.  Neurons secrete chemical messengers, called 
neurotransmitters, at chemical synapses to propagate electrical signals to be received by 
the post-synaptic neuron at its dendrites.  They also interact with support cells that 
provide trophic factors: Schwann cells in the PNS or astrocytes and oligodendrocytes in 
the CNS.  Schwann cells and oligodendrocytes coat most neurons with myelin protein 
that aids in the conduction of electrical signals.  Astrocytes promote the myelinating 
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activity of oligodendrocytes, modulate neurotransmitter uptake and release, and maintain 
synaptic plasticity36.  These cells have a significant effect on the regenerative process 
(See ‘PNS and CNS Responses to Injury’).  Microglia are another set of cells present in 
the CNS.  Sharing many properties with macrophages, they scavenge cell debris and 
secrete molecules that affect the immune and inflammatory response in the CNS. 
In the peripheral nerve, the myelin sheath envelops one or several axons, which is 
then surrounded by the endoneurium.  The perineurium wraps together several axons and 
their endoneurium to form bundles (fascicles).  A sheath of connective tissue called the 
epineurium surrounds several fascicles to form the nerve.  In the spinal cord, myelinated 
nerve bundles are found in the spinal tracts (white matter), which carry information to 
and from the brain.  Unmyelinated neurons are located in the gray matter, where synapses 
are formed between interneurons, sensory (afferent) neurons, and motor (efferent) 
neurons.          
 
 
1.4.2 PNS and CNS Responses to Injury   
Traumatic injury, as well as degenerative diseases, can considerably alter the 
architecture and function of peripheral and central nerves.  Though neurons and glia 
function similarly to propagate electrochemical signals in the PNS and CNS, these cells 
possess dramatically different regenerative responses after injury that depends on their 
environment.  Though CNS neurons were previously believed to be incapable of 
regeneration, it was shown that neuronal sprouting occurred from an injured spinal cord 
into a peripheral nerve graft, therefore indicating the role of environment in CNS 
regeneration37.  Increasing evidence supports the observation that the regenerative ability 
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of the nerve is highly influenced by permissive and non-permissive cues in the 
environment.  The different abilities of the CNS and PNS to promote growth may be 
attributed to the following: 1) in the PNS, the role of Schwann cells in providing trophic 
factors38; 2) in the CNS, the presence of myelin and myelin-associated inhibitors 39; 3) 
the suppression of apoptic pathways and activation of anti-apoptotic proteins40; and 4) the 
effect of the glial scar in spinal cord injury41.  Key events and the role of cellular 
components are summarized below.     
A myriad of neural cell-types, as well as cells of the inflammatory system, are 
involved in responses after PNS injury.  Upon transection, the distal portion of the nerve 
begins to degenerate due to protease activity and separation from the cell body or soma7 
(Figure 1.1a).  The proximal portion may also undergo apoptosis, depending on the 
neuron’s age, type, and distance of axotomy from the proximal end42.  Several hours after 
injury, growth-related molecules are upregulated, inducing axons and growth cones to 
sprout from the nodes of Ranvier and the soma.  During this time, Schwann cells play a 
key role in regeneration by increasing their proliferation to form Bands of Bünger and by 
secreting neurotrophic and chemotactic factors that influence growing axons, adjacent 
Schwann cells, and macrophages.  Schwann cells are also able to expedite the elimination 
of myelin, which inhibits axonal regrowth, by degrading their own myelin, phagocytosing 
extracellular myelin, and presenting myelin to macrophages.  Two to three days after 
injury, macrophages infiltrate the site to clear it of cell debris and myelin, which may 
require up to 2 weeks post-injury for completion.   
While small nerve gaps can be repaired by the human body, the regeneration of 
large nerve gaps (greater than 3 mm) is more difficult.  Greater control over the direction 
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of axon sprouting toward the distal nerve is desired, since inappropriate reconnections 
lead to neuropathic pain.  The direction and rate of axonal re-growth is affected by the 
presence of substrate or soluble cues that may be growth-permissive or repulsive.  
Effective spatio-temporal presentation of these cues may be used to better guide the 
growth cone.  In addition to axonal re-growth, improving the myelination of the sprouted 
axons is also likely to improve functional recovery.  This is a challenge since longer 
denervation of the remaining Schwann cells further reduces their capacity to support 
regeneration.   
Currently, there is no treatment that enables complete functional recovery after 
spinal cord injury, likely due to significant cell death and the presence of a growth-
inhibitory environment.  The spinal cord is incapable of regeneration without 
intervention.  Within thirty minutes of axotomy, the proximal and distal axons degenerate 
hundreds of microns (Figure 1.1b).  Axons that are not damaged by the initial injury also 
degenerate from secondary events.  The loss of axonal contact causes oligodendrocytes to 
undergo apoptosis 4-8 days after injury, which is significant since axons can survive up 
to 7 days post-injury.  Surviving oligodendrocytes revert to quiescence and, unlike their 
Schwann cell counterpart, contribute little to clearing myelin and axonal debris.  Myelin 
and myelin-associated components are inhibitors of axon growth in vitro.  Due to the 
blood-spine barrier and limited access to the injury site, macrophages do not play an 
appreciable role in myelin clearance.  Microglia, which are considered to play a role in 
CNS immune responses, increase proliferation 4-6 days post-injury but fail to develop 
into fully phagocytic cells.  Therefore, myelin can still be found several years after 
degeneration of the nerve.  In addition to myelin, glial scarring at the lesion is another 
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growth-inhibitory barrier that prevents regeneration.  The main inhibitory component of 
glial scars is chondroitin sulfate proteoglycans, molecules that are secreted by reactive 
astrocytes and are characterized by a protein core to which highly sulfated 
glycosaminoglycans are attached.  Chondroitin sulfate proteoglycan synthesis can be 
strongly increased and may be expressed as soon as 24 hours post-injury.  Therefore, the 
majority of current investigations in CNS nerve regeneration focus on increasing cell 
survival and creating a growth-permissive environment.  In addition, increasing the 
axonal elongation rate, directing axonal sprouting, and improving the myelination of 
newly sprouted and surviving axons are also highly relevant goals for achieving 
functional recovery in CNS repair. 
Biomaterial-based treatments may be used to encourage re-growth of the nerve 
after injury by integrating biochemical cues, providing physical guidance through a 
substrate, or both.   Biomaterials in the past have incorporated extracellular matrix 
(ECM) molecules that have adhesive and growth promoting properties.  They have been 
used to deliver neurotrophic factors to encourage survival of neurons and supporting 
cells.  The material itself may also have intrinsic properties which are not cell-derived 
that promote growth, such as the use of conductive materials to modulate the neuron’s 
electrical and chemical activities.  The material’s surface topology and its dimensions 
have also been used to guide neurite orientation.  In general, the goal of using materials in 
nerve tissue engineering is to enhance the regenerative process by creating a growth-
promoting environment and directing axonal growth to reconnect nerves for functional 
recovery. 
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Figure 1.1  Response after injury in the peripheral (a) and central (b) nervous 
systems43. 
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1.5 Biomaterials for Nerve Tissue Engineering  
1.5.1 Materials in Cell Therapies 
Cells may be delivered to the site of injury to replace lost cells, impart trophic 
support, or provide neuronal attachment sites through cell adhesion molecules.  Those 
that have been implanted for nerve regeneration include embryonic and adult stem cells, 
Schwann cells, olfactory ensheathing cells, and genetically modified cells expressing 
neurotrophic factors.  Transplantation of embryonic stem cells has improved locomotor 
function following spinal cord injury, likely by enhancing myelination and improving 
axonal conduction44.  In vivo implantation of neural progenitor cells derived from rat 
embryonic spinal cord has led to neurogenesis of the donor-derived cells and neurite 
extension of these cells into the host tissue45.  Ethical concerns associated with using 
embryonic stem and progenitor cells may make cell therapies using adult cells more 
feasible, at least in the short term.   Transplantation of adult-derived progenitor cells, 
which can also differentiate into oligodendrocytes in vivo, led to increased myelination 
and improved locomotion after spinal compression46.  Schwann cells, which are 
responsible for myelination in the PNS, produce a variety of growth factors, cell-adhesion 
molecules, and ECM that create a more permissive environment for nerve growth47,48.  
Schwann cells induced greater axonal ingrowth into the lesion47,49 as well as enhanced 
the responsiveness to electrical stimulation50 when implanted after spinal cord injury.  
Olfactory ensheathing glia cells have also been implanted following nerve injury because 
they express nerve growth factor (NGF), neurotrophin-4/5, neurotrophin-3, and brain 
derived neurotrophic factor (BDNF), and can remyelinate demyelinated spinal cord 
axons48.  Potential difficulty in isolating these cell types may be alleviated by genetically 
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modifying non-neural cell types to provide trophic support.  For exmple, fibroblasts 
expressing neurotrophin-3, neurotrophin-4/5, NGF, and BDNF have been delivered to 
injury sites of chronic and acute models of spinal cord injury51,52. 
Delivery of cells alone to the injury site often results in limited cell retention, 
likely due to cell death or migration from the site.  Biomaterials can be fabricated into 
scaffolds to locally deliver and promote the retention of the cells and neurotrophic 
molecules they secrete, as well as provide a physical construct to guide regeneration.  
Cell-seeded scaffolds may be more effective at guiding growth by localizing the presence 
of growth-stimulatory molecules.  Although growth factor secretion surrounding the site 
is desirable for creating a growth-permissive environment, random cell spreading may 
lead to non-directed growth of axons that can cause neuropathic pain.  Scaffolds with 
appropriate biochemical and physical cues may guide axonal extension and target 
regeneration toward the distal end of the severed nerve.  A scaffold may act as an 
effective barrier to inhibit the infiltration of cells that secrete growth-inhibitory molecules 
to the injury site.  The scaffold properties may also be controlled to improve cell loading, 
growth factor secretion, and cell differentiation for use of cell-seeded nerve guidance 
channels.  
 
1.5.1.1 Natural Materials for Cell Therapies 
Cellular Grafts.  Peripheral nerve grafts, fetal tissue grafts, and autologous vein 
grafts have been used to support axonal sprouting and extension in vivo.  CNS neurons 
can regenerate in a permissive environment, as evidenced by axonal sprouting from a 
transected spinal cord growing into a peripheral nerve graft53.  The ability of peripheral 
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nerve grafts to induce axonal sprouting after spinal cord injury also depends on the age of 
the recipient: adult rat supraspinal axons did not grow into sciatic nerve grafts while rat 
neonate neurons did54,55.  Although CNS axons extended into peripheral nerve grafts, 
various studies have indicated that animals receiving them were still unable to overcome 
functional deficits, which include paralysis and minimal hindlimb-forelimb 
coordination54.  Axons that entered the nerve grafts did so in a meandering, disorderly 
manner, unable to grow beyond the distal boundary of the host-graft interface54.  The 
inability of axons to cross the boundary indicates that the graft environment may be too 
growth-permissive to permit axonal exit from it.  Alternatively, the duration of axonal 
sprouting and extension through the peripheral nerve graft may permit scar tissue 
formation, which acts as a barrier for reconnecting the nerves.  While PNS nerve grafts 
are limited in promoting regeneration in CNS regeneration, there has been some success 
using fetal tissue grafts to promote neural reconnections across the distal graft-host 
interface.  Fetal spinal cord transplants rescued axotomy-induced retrograde cell death, 
specifically by preventing death of red nucleus neurons in adult rats55.  In a study 
comparing PNS nerve grafts with fetal spinal cord grafts, tissue that regenerated from the 
latter seamlessly integrated into the spinal cord and extended farther caudally than in the 
PNS grafts54.  Limited supply of such grafts and the ethical constraints surrounding their 
use makes the feasibility of using fetal spinal cord grafts in the clinic questionable.  
Though they have only been used in PNS regeneration, vein autografts may have 
applications in CNS repair, as they are more readily available and can be isolated from 
the patient for use in nerve repair.  The vein’s ability to promote axonal sprouting and 
myelination is still not equivalent to that of an autologous peripheral nerve.  However, 
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filling these grafts with collagen and adding Schwann cells to the vein scaffold improved 
their ability to promote peroneal56 and sciatic nerve57 regeneration.     
Polysaccharides.  Agarose, an alternating co-polymer of 1,4-linked 3,6-anhydro-
-L-galactose and 1,3-linked -D-galactose, forms a solid below its gel-solution 
temperature and can be used to encapsulate cells58,59.  It has been fabricated into nerve 
guidance scaffolds with uniaxial channels, either through a freeze-drying60 or a 
templating method24.  Scaffolds produced by both methods integrated into the spinal cord 
lesions, showing Schwann cell infiltration, axonal penetration, and angiogenesis through 
the channels.  Axonal growth can be further enhanced by adding BDNF, either through 
adsorption by rehydration of the agarose60, or by loading the channels with bone marrow 
stromal cells genetically engineered to secrete BDNF24.   
Proteins.  Collagen, an ECM protein, can be processed into hydrogels and 
fabricated into different types of scaffolds.  The dimensions of the scaffold and presence 
of Schwann cells influence collagen’s ability to promote growth.  Hollow nerve guides of 
collagen gel were used to investigate the effect of Schwann cell implantation following a 
thoracic level spinal cord lesion61.  When fabricated as hollow nerve guides, pure 
collagen grafts did not support in vivo axonal elongation or Schwann cell entry into the 
matrix.  The inclusion of Schwann cells significantly improved the regenerative response, 
wherein cell-seeded collagen channels promoted axonal sprouting by 14 days and 
myelination by 28 days after implantation.   
Gelatin, the hydrolysis product of collagen, has been investigated in nerve 
regenerative applications.  Hippocampal neural stem cells and Schwann cells have been 
encapsulated into gelatin foams to improve functional recovery after spinal cord 
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transection62.  Neural stem cells or Schwann cells, both transduced with an adenovirus 
expressing neurotrophin-3, were seeded into gelatin foam. The seeded forms were used to 
fill the transection site.  Animals that received either cell type contained significantly 
more neurons in the sensorimotor cortex, red nuclei, and Clarke’s nuclei than those that 
did not receive any treatment after spinal cord transection.  The higher number of neurons 
may be attributed to enhanced survival of the neurons, the differentiation of the stem cells 
into neurons, or trophic support provided by the Schwann cells.  With co-transplantation, 
hindlimb locomotor function was significantly increased while the expression of 
inhibitory chondroitin sulfate proteoglycans was suppressed.   
      While collagen and gelatin enables Schwann cell attachment and axonal 
extension, these ECM proteins must be isolated from animal or human sources.  For 
clinical applications, the risk of pathogen transmission via graft materials must be 
minimized.  Simultaneously, alternative materials that promote regeneration while 
reducing this risk are desirable.   
 
1.5.1.2 Synthetic Materials for Cell Therapies 
Polylactide (PLA) and poly(lactide-co-glycolide) (PLGA) are aliphatic polyesters 
and polyhydroxyacids have been used to deliver Schwann cells, genetically modified 
Schwann cells, and neural stem cells for in nerve tissue engineering.  Using a porous 
PLA scaffold, Schwann cells were implanted into a 12 mm sciatic nerve defect in rats.  
Compared to the isograft control, PLA scaffolds seeded with Schwann cells had nerve 
fiber density that was significantly lower after four months, with no difference in the 
mean sciatic functional index63.  The effect of implanting genetically altered Schwann 
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cells using PLA has also been investigated.  Schwann cells, modified to express a bi-
functional neurotrophin with BDNF and neurotrophin-3 activity, were encapsulated in a 
fibrin solution and implanted into a spinal cord defect using PLA macroporous 
scaffolds22.  Myelinated axons extended into the construct 6 weeks after implantation; 
however, the axons did not extend out of the scaffold containing transduced Schwann 
cells, nor was there complete functional recovery with this treatment.  Neural stem cells 
within PLGA scaffolds have also been implanted following hemi-section of the spinal 
cord in rodents.  Rats that received scaffolds with stem cells demonstrated significant 
improvement in open-field locomotion up to 28 days post implantation compared to rats 
that received cells alone or no treatment at all.64  However, there was no statistical 
difference in behavioral outcome between cell-seeded scaffold and scaffold alone. 
Poly(hydroxybutyrate) (PHB) is a bacteria-synthesized polymer that degrades into 
a non-toxic metabolite in mammals65.  Implanting neonatal Schwann cells using PHB 
fibers enabled axonal elongation into the rostral and caudal ends following a cervical 
spinal cord laminectomy65.  In another study, transplantation of a hollow PHB conduit 
seeded with Schwann cells into a 10 mm sciatic nerve gap resulted in longer axonal 
extension into the lesion compared to PHB conduits alone66.  Schwann cell delivery using 
PHB scaffolds appears to improve peripheral nerve regeneration as evidenced by the 
presence and close association of regenerating axons with Schwann cells66,67.  It is 
unclear whether Schwann cell-seeded PHB scaffolds would perform better than the gold 
standard for peripheral nerve regeneration, however, since no autograft controls were 
included in these experiments.   
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 Poly(acrylonitrile-co-vinylchloride) (PAN/PVC) is a co-polymer with substantial 
tensile strength that has also been used to investigate the potential therapeutic effects of 
Schwann cells.  The effect of Schwann cells in eliciting axonal growth after spinal cord 
transection was explored using PAN/PVC nerve guides loaded with Schwann cells in 
Matrigel68.  One month after implantation of the nerve guide channels, Schwann cell-
seeded constructs exhibited significantly greater myelination and an eight-fold increase in 
umyelinated axons over Matrigel-only control68.  PAN/PVC guidance channels seeded 
with Schwann cells were also used to determine that regenerated CNS axons responded 
to electrical stimulus and conducted action potentials after spinal cord transection50.  
Although PAN/PVC is not biodegradable, its presence did not preclude axonal extension, 
myelination, or re-establishment of electrical connections.  The PAN/PVC channels 
minimized connective tissue infiltration but contributed to grey matter necrosis of the 
spinal cord69.   
 Administration of neurotrophins in conjunction with Schwann cell implantation 
showed promise in eliciting axons to cross the graft-host boundary.  The infusion of 
neurotrophin-3 and BDNF distal to a Schwann cell-filled PAN/PVC channel allowed 
more axons to re-enter the distal cord after spinal cord laminectomy, with each 
neurotrophin promoting a different morphology of axonal sprouting70.  In addition to 
improving the ability of axons to traverse the lesion, growth factor delivery can also 
enhance myelination.  Adding glial derived neurotrophic factor (GDNF) to a Schwann 
cell-seeded PAN/PVC channel increased the myelination of axons three-fold, from 11% 
myelinated axons to 33%71.   
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1.5.2 Neurotrophin-containing Materials 
The failure of cells to activate regeneration-associated genes and the 
accompanying lack of neurotrophic support are main contributing factors that hinder 
nerve repair72,73.  The application of neurotrophins has been associated with inducing the 
growth of specific subpopulations of axons, facilitating synaptic transmission, and 
improving functional recovery74-77.  The ability of growth factors to impart a positive 
effect on regeneration has been assessed by directly injecting the molecule of interest to 
the injury site, or by delivering it via cells or polymer vehicles.   
Utilizing biomaterials to deliver growth factors may enable spatio-temporal 
control over the presentation of bioactive molecules.  It is important to locally stimulate 
regeneration, since non-directed neurite sprouting can cause neuropathic pain.  
Biomaterials have the potential to achieve local, sustained delivery of neurotrophic 
factors by encapsulating, facilitating electrostatic interactions, or covalently incorporating 
them.  However, free growth factors are rapidly decomposed by enzymes in the body. A 
biomaterial delivery matrix can stabilize growth factors, which have a very short half life 
in the body78,79.  Using a biomaterial, in effect, may increase the amount of available 
neurotrophic factor by concentrating it to the desired site of delivery and by preventing its 
degradation once inside the body.  The ability to deliver multiple growth factors in a 
controlled manner over time is also desired, as a variety of neural and inflammatory cells 
are involved following nerve injury.   
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1.5.2.1 Natural Materials for Neurotrophin Delivery 
Polysaccharides. Alginate and agarose are polysaccharide-based hydrogels that 
have been used as delivery vehicles for growth factors and scaffolds for CNS and PNS 
repair.  Alginate encapsulation of growth factors has been used concurrently with 
autologous nerve transplant in repairing the sciatic nerve.  Calcium alginate, an FDA-
approved polysaccharide, facilitated continuous release of encapsulated BDNF over 8 
weeks in vitro80.  When implanted with autologous fascia tubes to regenerate a 20 mm rat 
sciatic nerve gap, animals receiving the treatment exhibited greater nerve fiber elongation 
and significantly less auto-cannibalization, an indicator of neuropathic pain in rats.  
Agarose is liquid above its gelation temperature and can be used to fill irregular cavities 
that develop from an injury.  A combination of an agarose scaffold with BDNF-loaded 
lipid micro-tubes has been tested to treat spinal cord injury81.  Compared to an agarose-
only scaffold, the addition of BNDF enhanced axonal extension into the construct.  No 
regenerating fibers, however, re-entered the host tissue81.  While the addition of growth 
factors beyond the lesion may promote axon sprouting into the distal region, it is also 
possible that glial scarring at the boundary or the presence of other inhibitory cues play a 
role.    
The effect of growth factor gradients, presented in soluble form or immobilized 
within a material, can alter neurite growth.  With agarose scaffolds, the effects of NGF 
amounts and concentration gradients on neurite extension were tested in vitro.  A 
compartmentalized diffusion chamber was utilized to create a concentration gradient of 
soluble NGF within the middle well that contained PC12 cells82.  The gradient, not the 
absolute concentration, guided the direction of neurite growth.  The potential of an 
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anisotropic environment to promote regeneration was also assessed in an agarose scaffold 
containing gradients of laminin and NGF83.  Following a 20 mm rat sciatic nerve gap, 
only animals receiving grafts with gradients of both laminin and NGF elicited axonal 
sprouting into the agarose scaffolds.  Though anisotropic grafts led to comparable sciatic 
nerve re-innervation compared to the autologous nerve, the resulting re-innervation with 
these treatments were still considerably lower than that provided by the native muscle83.  
Additionally, immunohistochemical staining revealed that nerve grafts and anisotropic 
scaffolds were deficient in synapses that co-stained for pre- and post-synaptic markers, 
compared to native nerve83.  Though regeneration of axons may improve the re-
innervation of muscles, re-establishing synaptic connections may also be as critical for 
complete functional restoration. 
Proteins.  Proteins that have been used for neurotrophic delivery include gelatin, 
collagen, fibronectin, silk, and fibrin.  The growth factor was incorporated into the 
protein either through physical adsorption, entrapment, or covalent modification of the 
material.   
Immobilizing growth factors onto scaffolds may prolong the presence of a 
bioactive molecule at the site of injury.  NGF, BDNF, and insulin like growth factor-1 
(IGF-1) have each been covalently bound onto gelatin-tricalcium phosphate for repairing 
a sciatic nerve gap84.  Electrophysiological studies showed that animals receiving NGF, 
BDNF, and IGF-1 exhibited a compound muscle action potential, whereas animals 
treated with gelatin did not.  An increase in gastrocnemic muscle weight ratio, a measure 
of muscle re-innervation, was seen with BDNF treatment, but there was no difference in 
sciatic functional index between control and growth factor treatments.  It is important to 
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note that in this study, all growth factors were tested individually and each at the same 
concentration.   
It is possible that the potency of eliciting regeneration varies according to growth 
factor, and that regeneration can be enhanced by using different concentrations of each.  
Collagen gels were used to study the effects of soluble NGF, GDNF, and CNTF 
concentrations on DRG neurite growth85.  This study determined that the optimal 
concentration for eliciting the longest neurites was different for each growth factor, and 
demonstrated the potential to further enhance regeneration using a combination of soluble 
growth factors at varying concentrations. 
To enhance regeneration, the release profiles of growth factors may be 
manipulated by taking advantage of differences in interactions between the growth factor 
and materials used to deliver them.  Variations in handling and preparation of the same 
material-growth factor combination can be sufficient to affect the release profile.  NGF, 
encapsulated into silk fibroin nerve channels, was released faster into buffer when the 
scaffolds were prepared by air-drying than those by freeze-drying86.  In another study 
utilizing non-covalent interactions, the delivery of neurotrophin-3 adsorbed onto 
fibronectin mats into a 10mm rat sciatic nerve defect led to increased axonal extension 
and more myelinated axons compared to fibronectin-only scaffold87.   
Affinity-based binding of the growth factor to the delivery matrices may stabilize 
the growth factors and control their release.  In directed affinity-based loading, 
interactions that promote binding of the growth factor onto the matrix appear to improve 
bioactivity.  The binding of NGF-to collagen was enhanced by generating a fusion 
protein containing the primary sequence of mature NGF-the collagen-binding 
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polypeptide TKKTLRT, and a histidine purification tag88.  When compared to soluble 
NGF of equivalent concentration, collagen-bound NGF elicited greater neurite outgrowth 
and increased survival of PC12 cells, indicating its potential application in nerve repair.  
A similar approach in the controlled release of growth factors utilized the affinity 
between heparin and heparin-binding growth factors.  An immobilized heparin-binding 
peptide on a fibrin matrix was used to sequester heparin, which subsequently bound 
bFGF, NGF- BDNF, and neurotrophin-389,90.  Delivery of these growth factors to dorsal 
root ganglia led to significantly longer neurites89,90.  An in vivo study showed increased 
neural fiber sprouting and integration with neurotrophin-3 and the heparin-based delivery 
system nine days after acute spinal cord injury; however, there was no improvement in 
hindlimb motor function at 12 weeks91,92.  A modification to this fibrin-based delivery 
system utilized phage-display to identify peptides with NGF affinity93.  Consensus 
sequences having significant ability to promote NGF binding were identified and coupled 
to fibrin via the Factor XIIIa substrate (in italics): NQEQVSPNQSPNHTQNRAY, 
NQEQVSPQMRAPTKLPLRY, NQEQVSPSVSVKAKKSVNR).  While the release 
profile could be tailored according to the peptide used, an in vitro study showed no 
significant difference in neurite length using the peptide affinity-based delivery system. 
 
1.5.2.2 Synthetic Materials for Neurotrophin Delivery 
A variety of growth-factor modified, synthetic polymers have shown potential for 
applications in nerve tissue engineering.  Synthetic materials have delivered physically 
entrapped neurotrophins, which can be used to create a gradient within scaffolds.  
22 
Additionally, polymers have also been used to facilitate genetic modification of cells in 
order to impart them with an ability to produce growth factors. 
Growth factor delivery and topographical guidance using a co-polymer of poly-
caprolactone and ethylene phosphate has been investigated in sciatic nerve regeneration.  
Animals treated with co-polymer that had been electrospun with BDNF exhibited 
significantly greater number of myelinated axons than fibers without BNDF28.  
Longitudinally aligned fibers containing BDNF promoted significantly more 
electrophysiological recovery in rats compared to no treatment; however, there was no 
significant difference with fibers without BDNF.   Topological guidance via electrospun 
poly-caprolactone and ethylene phosphate was sufficient at promoting 
electrophysiological recovery.  Further behavioral testing is needed to assess the effect on 
functional improvement.     
Synthetic polymers have been used to entrap neurotrophic factors within scaffolds 
or microspheres in order to modulate nerve growth.  A PLA tubular scaffold delivered 
BDNF to treat acute spinal cord transection, enhancing neuronal survival at the rostral 
interface and more rapid axonal growth into the implant23.  Axons were found earlier 
within BDNF-foams, but did not translate into behavioral improvement over scaffolds 
without BDNF.  Another entrapment strategy involves encapsulation of the bioactive 
molecule to effectively control the rate of growth factor release.  Controlled release of 
NGF has been investigated using PLG, PLGA25,94, pHEMA-pMMA94, allowing NGF to 
be delivered from 220 pg to 8624 pg per cm of scaffold.  Properties of the guidance 
channels, such as the molecular weight of the polymer or porosity of the scaffold, were 
also tailored to vary the release rate of neurotrophic factors from the scaffold25.  The 
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appropriate release kinetics that are effective at creating a growth-permissive and pro-
survival environment are still to be determined, as these advanced delivery techniques 
have not been tested in vivo.   
Electrical modulation of conducting polymers doped with growth factors may be 
used to control spatio-temporal presentation of growth factors.  NGF and neurotrophin-3 
have been incorporated into polypyrroles and their effects tested in vitro.  NGF that was 
entrapped during the polymerization of a conducting polymer maintained its bioactivity 
and induced neurite extension from PC12 cells95.  Because the polypyrrole-NGF 
composite did not adequately promote cell attachment, collagen was also incorporated to 
improve adhesion95.  Electrical stimulation of polypyrroles containing neurotrophin-3 
released more growth factor than unstimulated composites96,97, likely leading to greater 
neurite outgrowth seen on stimulated polypyrrole with neurotrophin-3 than on 
unstimulated composite.     
Growth factors have also been immobilized onto synthetic polymers.  
Immobilized NGF on poly(dimethyl siloxane) maintained its ability to elicit axonal 
extension from hippocampal neurons in vitro98.  Similar enhancement in polarization and 
neurite extension in culture was observed when 0.11 ng/mm2  of immobilized NGF 
(determined by a FITC-conjugated NGF assay) or 50 ng/ml of soluble NGF was added to 
the same surface.  NGF covalently bound onto pHEMA also retained its bioactivity, 
demonstrated by the ability of the NGF-pHEMA material to cause PC12 differentiation 
and subsequent neurite extension99.  In another study, immobilized gradients of NGF and 
neurotrophin-3 within pHEMA hydrogels were created in order to assess the effect on 
neurite guidance.  Dorsal root ganglia responded to an immobilized gradient of NGF at 
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310 ng/ml-mm by orienting neurite growth up the gradient.  Furthermore, a lower NGF 
gradient of 200 ng/ml-mm and neurotrophin-3 gradient of 200 ng/ml-mm100 elicited 
guidance, indicating a synergistic effect of the two growth factors on neurite orientation.  
It is important to clarify that such combination effect is not always observed85, and may 
depend on growth factor concentrations as well as the co-localization of neurotrophic 
receptors100.  Further investigation is needed to determine which growth factors work in 
concert to promote regeneration and the mechanisms by which immobilization affects 
growth responses.  The conducting polymer polypyrrole has also been covalently 
modified with NGF.  The combination of electrical and bioactive stimulation 
significantly enhanced neurite length after 2 days101; however, it was not reported 
whether electrical stimulation prompted increased release of the immobilized NGF. 
The methods discussed here have so far utilized materials to deliver bioactive 
molecules; biomaterials may also be used as carriers of genetic information to impart 
cells with the ability to produce growth factors.  Using PLGA-mediated DNA delivery, 
cells were induced to produce bioactive NGF that was capable of eliciting neurite 
extension from dorsal root ganglia.  cDNA complexed with Lipofectamine was 
incorporated into PLGA disks by compression molding, which were then used as 
substrates for cell-seeding to enhance transduction102.  The transfection efficiency using 
PLGA-mediated lipofection reached 48%.  PLGA patterned with microchannel widths 
ranging from 100 to 250 m have also been used for localized DNA delivery103.  The 
channel width affected the transfection efficiency; the 100 m-wide channels exhibited 
16% efficiency whereas the 250 m-wide channel transduced 52% of the cells.  Cells 
which take up the cDNA can continuously produce the growth factor without depletion. 
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1.5.3 ECM protein-modified Materials 
ECM components are widely used in tissue engineering applications104 and their 
particular effects on neural responses have been investigated105-108.  ECM molecules 
influence a variety of cellular processes that include cell migration, axonal guidance, 
synaptogenesis, survival, differentiation and myelination109,110.  ECM proteins are likely 
substrates for treating nerve injury because components such as laminin, 
thrombospondin, vitronectin, and fibronectin have been found to support axonal 
extension during CNS development110.  Of these proteins, laminin is the most 
investigated in nerve tissue engineering applications for its ability to affect neuronal 
growth, survival, and guidance.  When compared against collagens, proteoglycans, and 
fibronectin, laminin was most effective at promoting neurite outgrowth111 and also has 
the ability to elicit outgrowth from a variety of central and peripheral neurons112,113.  
Additionally, particular domains on laminin promote neuronal survival114 and can induce 
growth cone turning115-117.  To impart bioactivity to polymers, most biomimetic 
approaches have focused on particular domains of laminin, including IKVAV, 
RNIAEIIKDI118-120, YIGSR, and RGD112,121,122.  These epitopes have been integrated into 
materials to take advantage of the ECM’s cell adhesive and growth-promoting properties.  
The materials may be derived from natural polymers (polysaccharide-based and protein-
based) or synthetic polymers.     
 
1.5.3.1 ECM protein-modified Natural Materials 
Polysaccharides.  Agarose has been covalently modified with laminin and its 
epitopes to enhance neuronal adhesion, sprouting, and axonal extension.  The presence 
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and density of laminin cues have been found to affect neuronal responses.  
Immobilization of YIGSR in three-dimensional agarose gels led to enhanced neurite 
extension in vitro123,124  and significantly greater myelination of spinal cord axons in vivo 
relative to agarose124.  Neuroblastoma cells attached and sprouted neurites in a dose-
dependent manner when seeded onto YIGSR-agarose125, a trend that was similarly 
observed in neurite sprouting from dorsal root ganglia cultured on YIGSR-fibrin 
substrates126.  The steepness of the gradient also has an effect on neurite extension rate.  
A bi-phasic response to the gradient steepness was observed while testing the effect of 
immobilized gradients of laminin in agarose and an optimal laminin gradient that 
promoted the fastest growth rate in vitro was determined127.  Interestingly, when laminin-
gradient scaffolds were implanted following a 20 mm peripheral nerve gap in the rat, the 
laminin gradient alone did not lead to axonal regeneration, unless an NGF gradient was 
presented simultaneously83.   
While immobilized gradients may direct axonal growth, creating selectively 
adhesive regions of agarose has also been used to guide axonal elongation.  Agarose was 
modified with photosensitive S-2-nitrobenzyl-cysteine and exposed to a focused laser 
beam to selectively incorporate GRGDS pentapeptide into 150 to 170 m-wide 
channels128.  The cell-adhesive channels guided neurite outgrowth from dorsal root 
ganglia.  This method may be potentially useful in preventing neuropathic pain by 
controlling the spatial presentation of cell adhesive regions and guiding axonal 
reconnection to the targeted organ.   
Chitosan scaffolds have been utilized in various tissue engineering applications 
and are generally considered biocompatible with many tissues129,130.  Covalently 
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modified chitosan with YIGSR and IKVAV (each at 780 nmol per gram of chitosan) has 
enhanced neuronal adhesion, sprouting, and neurite extension in vitro when compared 
with un-modified chitosan131.  Incorporation of either YIGSR or IKVAV significantly 
promoted superior cervical ganglion cells extend longer neurites on chitosan, and the 
immobilization of both peptides induced greater neurite extension than either IKVAV or 
YIGSR alone131.  Nerve guidance channels made of YIGSR- or IKVAV-modified 
chitosan were reported to mediate neuronal sprouting in vivo following sciatic nerve 
injury, but did not significantly improve terminal latency compared to isograft132,133.   
Multiple laminin epitopes may also be used to maximize adhesion and neurite 
extension.  Covalently modified methacrylated dextran with either RGD or YIGSR and 
IKVAV dissimilarly affected neurite length134.  Although there was no significant 
difference in the adhesion of dorsal root ganglion neurons, the average number of 
neurites was considerably greater on the material with both YIGSR and IKVAV than on 
RGD-modified dextran134.  The higher concentration of laminin epitopes might have 
attributed to the improved sprouting, as the peptide content of the YIGSR and IKVAV-
containing scaffold was approximately twice that of the construct modified with RGD.  
The improved efficacy of incorporating multiple peptides on neurite extension and length 
has been demonstrated on agarose123 and on chitosan131 as well.  New materials 
displaying a combination of peptides may be synthesized using the photo-conjugation 
technique described in the incorporation of RGDS into hyaluronan135 and agarose128.    
Alternatively, the entire laminin molecule may be tethered to materials to impart them 
with its growth promoting properties.  For example, methylcellulose covalently modified 
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with laminin may be useful in nerve repair by enhancing the viability of CNS neurons in 
cell transplantations136.   
Proteins.  Collagen and fibrin modified with ECM derived domains have 
demonstrated effects on myelination, growth factor secretion, and neurite extension.  
Combinations of different peptide sequences and their potential interactive effects have 
been investigated using fibrin-based materials.  Both collagen and fibrin are naturally-
derived, and are, therefore, readily degraded in vivo.  Collagen has been used in repairing 
peripheral nerve gaps137-139, while fibrin can regulate neural cell activities after nerve 
injury140,141.    
Collagen has been used to investigate how immobilization of laminin epitopes 
affects neurite sprouting and sciatic nerve regeneration.  Collagen has been modified by 
cross-linking collagen with YIGSR-conjugated dendrimers142.  Dorsal root ganglia 
cultured on YIGSR-modified collagen sprouted greater and longer neurites than on 
unmodified collagen.  Using an RGD-conjugated collagen construct (with 3.5 nM/cm2 
peptide), sciatic nerve regeneration of a 10 mm gap in rats was significantly improved by 
30 days compared to a collagen scaffold143.  The RGD-modified collagen considerably 
enhanced functional recovery better than collagen or autograft treatments, as indicated by 
a higher sciatic functional index and statistically improved nerve conduction velocity.  
The presence of the RGD scaffold is thought to induce the proliferating cells adhered to 
the construct to secrete trophic factors.  Collagen conduits covalently modified with 
RGD, GHK (found in laminin and collagen), and KRDS (found in human lactoferrin) 
also affect growth factor production when implanted into 10 mm sciatic nerve gap in 
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rats139.  Peptide-modified scaffolds exhibited an upregulation of NGF, neurotrophin-3, 
NT-4, and GAP-43, when compared to unmodified collagen control.   
A fibrin matrix incorporating the peptides IKVAV, RGD, HAV, YIGSR, and 
RNIAEIIKDI has been used to investigate the optimal peptide density for maximizing 
neurite growth126.  A synergistic effect was observed between RGD, YIGSR, IKVAV, 
and RNIAEIIKDI, and scaffolds containing these peptides contained significantly more 
axons than un-treated or un-modified fibrin.  The synergistic effect was observed with 1.7 
mole of peptide (for IKVAV, YIGSR, and RNIAEIIKDI) per mole of fibrinogen, a lower 
amount of each peptide that is needed for maximizing axonal extension than when the 
peptide is used independently. Considering the potential interactions between various 
ECM peptides may give insights into developing materials that effectively promote 
regeneration and provide greater understanding over the biological pathways involved. 
Recently, keratin derived from human hair was shown to have neuroinductive 
effects106.  Keratin hydrogel was obtained after oxidizing the cross-links within the 
protein and isolating the gamma and alpha keratins.  More Schwann cells attached onto 
keratin than fibronectin surfaces in vitro.  When implanted into a 4 mm defect in mice 
tibial nerve, the keratin hydrogel promoted better functional improvement over an 
autograft control.  The conduction delay was significantly lower and the amplitude of the 
motor action potential statistically better over an autograft control.  It will be interesting 
to see this material’s efficacy at regenerating longer peripheral nerve gaps or the spinal 
cord.  
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1.5.3.2 ECM protein-modified Synthetic Materials 
Synthetic materials may incorporate ECM components through either surface or 
bulk modification.  Factors that may determine the manner in which the material is 
altered include the following: 1) presence and ease of access to appropriate functional 
groups; 2) intended application of the finished material (i.e. film vs. scaffold); and 3) 
whether the bulk properties of the material need to be preserved in the material’s 
application.  For materials that lack accessible functional groups to allow the conjugation 
of ECM analogues, surface modification might be the only feasible method to create 
functional groups that would permit covalent modification with peptides or protein.  
Surface modification could promote cell interactions with the material surface when 
maintaining material bulk properties is desirable.  
Low cell adhesion to fluoro-polymers and their current use in the clinic make 
them attractive for surface modification with peptides to encourage selective attachment 
of neural cells and neurite growth.  Including a flanking unit for the epitope may allow 
the peptide to be presented more closely to its native conformation in laminin144.  
Covalently attaching extended peptides of YIGSR and IKVAV to ePTFE increased 
neurite length, though it is unclear whether this difference was statistically significant.  
Fluorinated polypropylene was also modified on the surface with YIGSR and IKVAV, 
each at 3.6 fmol/cm2, leading to significantly greater and longer neurites than using either 
peptide alone145.  The presence of two adhesive domains and the higher concentration of 
peptides likely encourage more cells to bind to the material, while the presence of a 
neurite-growth promoting domain significantly enhances neurite outgrowth.  Another 
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study also confirmed that introduction of CDPGYIGSR onto hydroxylated fluorinated 
ethylenepropylene and PVA surfaces enabled the adhesion of neuroblastoma cells146.   
Surface modification of polypyrroles is important, since directly incorporating 
bioactive cues in bulk polymers can alter their conductive properties.  Polypyrroles that 
contain a carboxy end have been synthesized to enable the attachment of RGD to the 
polypyrrole surface147.    Covalent attachment of ECM analogues to these conducting 
polymers may improve their applications as neural probes and scaffolds148 for nerve 
repair by facilitating cell-material interactions.  Another approach to modifying 
polypyrrole surfaces with laminin-epitopes is through non-covalent interactions.  Using a 
bacteriophage library to identify peptides that are particularly adhesive to polypyrroles, 
GRGDS was grafted on polypyrrole and enabled PC12 cells to adhere to the material149.  
The adhesive peptides stably bound to the polypyrrole in the presence of serum for up to 
21 days.          
 Synthetic polymers that are bulk-modified with ECM epitopes are mostly 
hydrogels.  Poly[N-(2-hydroxypropyl)methacrylamide] (pHPMA) has been modified 
with RGD for in vivo implantation for CNS nerve regeneration, while poly(ethylene 
oxide) (PEO), pHEMA, and self-assembling peptide nanofibers are currently being 
investigated in vitro for their ability to promote neurite sprouting and extension.   
RGD-modified pHPMA scaffolds had a higher density of axons than compared to 
unmodified pHPMA when implanted into the lesioned optic tract, cerebral cortex150, or 
following spinal cord laminectomy151.  Peptide-conjugated scaffolds also exhibited 
greater vascularization, and were infiltrated by astrocytes and macrophages.  While 
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vascularization of tissue engineered nerves can facilitate the exchange of nutrients and 
waste, the presence of astrocytes may inhibit nerve regeneration.   
In vitro testing of ECM-modified biomaterials showed that they promote neural 
adhesion and sprouting, and may influence stem cell differentiation.  Immobilized 
fibronectin on PEO was more effective at eliciting neurite extension from dorsal root 
ganglia compared to similar concentrations of adsorbed fibronectin on polystyrene152.  At 
similar fibronectin concentrations, between 200 ng/cm2 and 340 ng/cm2, the immobilized 
fibronectin elicited neurites to extend twice as long as adsorbed fibronectin.  pHEMA has 
also been modified with both CDPGYIGSR and CQAASIKVAV to enhance neuronal 
adhesion and extension26.  pHEMA scaffolds containing 92 to 106 mole/cm2 of peptide 
supported attachment and neurite outgrowth from dorsal root ganglia that were 
comparable to laminin and poly-L-lysine covered surface.   
Non-laminin based ECM epitopes have also been used in developing biomimetic 
materials for nerve regeneration.  Covalently linking a tenascin-derived peptide into 
UltraWeb (an electrospun polyamide matrix) has enhanced neurite outgrowth in vitro153.  
Tenascin-C, particularly the alternatively spliced fibronectin type-III repeat D region of 
this ECM molecule, contains the neurite outgrowth-promoting peptide VFDNFVLK154.  
The peptide significantly enhanced neurite outgrowth on proteoglycans and was more 
effective than laminin-1, L1 fused to human immunoglobulin, or intact tenascin-C.  
Compared to its soluble forms, conjugated fibronectin152 and tenascin-C peptide153 
elicited improved neurite extension from dorsal root ganglia, cerebellar granule, cerebral 
cortical, hippocampal, and motor neurons.  This difference in response may be due to 
differential activation of signaling pathways that depends on bound substrates.   
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Another approach to potentially enhance nerve regeneration is by replacing the 
loss of neurons after injury through biomaterial-induced differentiation of neural 
progenitor cells.  Under regular cell culture conditions, including the use of laminin 
matrix, most neural progenitor cells will differentiate into glia.  Self-assembling 
nanofibers were modified with IKVAV to facilitate differentiation of neural progenitor 
stem cells into neurons155.  Neural progenitor cells that were encapsulated within the gel-
like scaffolds migrated within the nanofiber matrix and exhibited neurite outgrowth.  
IKVAV-modified nanofibers significantly promoted a higher percentage of stem cells to 
differentiate into neurons than on the laminin and PDL after 7 days.  Interestingly, the 
incorporation of IKVAV into other synthetic polymers has not resulted in enhanced 
differentiation of progenitor cells.  IKVAV-modified phospholipid bilayers, which 
present the epitope on the surface, did not induce neuronal differentiation over laminin 
after 8 days156.  Neuronal differentiation was also unaffected when using interpenetrating 
polymer network of poly(acrylamide-co-ethylene glycol/acrylic acid) that had been 
modified with IKVAV versus laminin157.  These differences in observations may be 
attributed to the variations in the density of IKVAV presented on the material or to the 
mechanical properties of the substrate.  The self-assembled nanofibers are estimated to 
present 7.1x1014 IKVAV/cm2 155, whereas the phospholipid bilayers are capable of 
presenting up to 1.64x1013 IKVAV/cm2 156.  The higher epitope concentration in the self-
assembled nanofibers may be required to induce differentiation.  Additionally, cell 
interactions with the synthetic substrate of the material (i.e. peptide amphiphile vs. 
phospholipid vs the IPN polymer) and source of the neural progenitor cells (cortical- vs. 
34 
hippocampal-drived stem cells) may also account for differences in these materials’ 
ability to affect differentiation.  
In addition to ECM-derived proteins, the L1 cell adhesion molecule has also been 
used to modify biomaterials.  L1 is primarily expressed in the nervous system – on the 
surface of Schwann cells, olfactory ensheathing cells, the axon, and the growth cone158.  
L1 has been implicated in the adhesion, neurite outgrowth, and guidance of neurons159,160.  
L1-modified PEO may improve nerve regeneration by supporting the selective 
attachment of cerebellar neurons over astrocytes and meningeal cells when all three cells 
were simultaneously seeded161.  Coatings of PEO that had been activated with pyridyl 
disulfide were incubated overnight with reduced L1 to create a bioactive surface.  
Hippocampal neurons and dorsal root ganglia neurons adhered to and extended neurites 
on the L1-modified substrate.  Though the adhesion was assessed at 24 hours after 
plating, the short-term selective attachment of neurons may be beneficial for retaining 
surviving neurons following injury.   
 
1.5.4 Conductive Materials 
Electrical activity affects both the developing nervous system and the regenerative 
processes that occur after nerve injury.  Immature cerebellar granule cells have been 
induced to proliferate through the depolarization caused by the neurotransmitter -
aminobutyric acid162.  Electrical changes through calcium transients also play a role in 
growth cone turning163 and dendrite growth164,165.  Direct application of electrical fields 
to neurons also has been shown to guide neurite growth.  Neurons responded to field-
induced membrane depolarization with neurite initiation and elongation166,167.  Pre-
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exposure to brief electrical stimulation has also converted the repulsive effect of soluble 
myelin-associated glyocoprotein to a growth-cone attractive molecule in frog neurons168.  
These observations have led researchers to investigate the potential roles of electrical 
stimulation following nerve injury.   
There has been some improvement seen in axonal sprouting and extension in the 
presence of electrical stimulation.  Animals that received direct current electrical 
stimulation at 0.6 A and 1.35 V exhibited axons that traveled farther into the lesion site 
after sciatic nerve injury, when compared the un-stimulated group169.  Short or long-term 
electrical stimulation appears to be effective, as continuous electrical stimulation for 1 
hour or 2 weeks were both effective at accelerating the re-growth of the femoral 
motorneurons170.  Electrical induction may accelerate growth by up-regulating 
neurotrophic factors or increasing sensitivity to the growth factor by increasing the 
expression of its receptor.  Increased expression of BDNF, mRNA levels of trkB (BDNF 
receptor), and growth-associated protein 43 have been observed up to 2 days after only 1 
hour of stimulation170,171, and are thought to be involved in electrically-induced axonal 
regeneration.   
In spinal cord injury, voltage gradients also promoted axonal extension into the 
lesion172,173, with 60% of animals having regenerating axons present compared to 12% of 
animals without stimulation172.  Compared to un-stimulated animals which showed no 
recovery in muscle reflex after spinal cord hemisection, 25% of animals that received 
electrical stimulation exhibited recovery174.  Phase 1 clinical trials evaluating the effect of 
a human oscillating field stimulator on patients with complete motor and sensory spinal 
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cord injury also indicate that patients exhibited improved response in light touch, 
pinprick sensation, and motor status175.    
Conducting polymers have been mostly investigated for improving neural probes 
and biosensory applications.  They are of main interest in nerve tissue engineering as they 
can provide a substrate that 1) locally delivers electrical stimulation, 2) be employed as a 
delivery vehicle for neurotrophins or small molecules that can enhance regeneration.  
Piezoelectric polymers and polypyrroles comprise most conducting materials, the latter of 
which is more commonly investigated due to the ability to control the amount and 
duration of electrical stimulation. 
 
1.5.4.1 Piezoelectric Materials 
Mechano-electrically stimulated, piezoelectric materials have shown potential as 
nerve tissue engineering materials by enhancing neurite extension, orientation, and 
myelination176.  The polymers polyvinylidenefluoride (PVDF) and poly(lactic-co-glycolic 
acid) were rendered piezoelectric through a corona poling process (Figure 1.2), enabling 
them to generate an average voltage of 2.5 mV when placed on incubator shelves.  
Vibrations caused by the incubator were sufficient to generate small deformations and the 
corresponding electric field; in vivo implantation of a PVDF nerve guide is likewise 
expected to induce a voltage potential.  In serum-free media, statistically greater 
neuroblastoma cultured on poled substrates extended neurites (approximately 59% vs. 
42% at 96 hours), and neurites were also statistically longer (an estimated 270 mm vs. 
200 mm, as ascertained from presented graphs) than cells cultured on unpoled substrates.  
Poled PVDF tubular nerve guides used to regenerate a 4 mm sciatic nerve gap have also 
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exhibited biocompatibility and promoted significantly greater myelination of axons 
compared to unpoled PVDF, acrylic copolymer, polyethylene, poly tetrafluoroethylene, 
and silicone elastomer177,178.  The ability of poled materials to elicit regeneration 
compared to autograft controls were not reported, nor was functional recovery through 
behavioral assessment made.  The effect of the poling process on increasing myelination 
in vivo has also been observed using poled PLGA179.  Regeneration on PLGA that was 
poled at 24 kV for 45 minutes led to significantly more myelinated axons and faster 
conduction velocity than constructs that were poled at 20 kV for 10 minutes179.  
 
 
Figure 1.2.  Corona poling device for rendering polymer tubes piezoelectric.  
Appling a high voltage d.c. field across the wall of the channel aligns dipoles within the 
polymer crystals.  A: longitudinal view, B: Cross-sectional view of poling device178.  
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1.5.4.2 Polypyrrole 
Polypyrrole’s conjugated structure of alternating C=C double bonds and C-C 
single bonds imparts them their electronic properties.  Polypyrrole has been used to 
deliver electrical stimulation to PC12 cells, thereby significantly increasing neurite 
extension180,181.  Their biocompatibility is similar to PLGA, eliciting equivalent or less 
inflammatory response when implanted subcutaneously or intramuscularly180.  The use of 
polypyrroles in nerve repair has been limited due to their non cell-adhesive and 
permanent nature148, the latter being a concern for long-term, in vivo implantation.  The 
synthesis of polypyrroles is also limited to thin films due to the requirement to synthesize 
it onto an electrode182.   
Many efforts have focused on improving polypyrrole’s cell adhesiveness while 
simultaneously maintaining its conductive properties.  Surface-modification of 
polypyrroles with ECM or ECM-derived epitopes has attempted to enhance cell adhesion.  
Electrodeposition of polypyrrole with polyglutamic acid (polypyrrole-Glu) enabled the 
covalent attachment of polylysine and laminin onto its surface183.  Dorsal root ganglion 
neurons attached onto the modified surface183, however the effect of electrical stimulation 
on neuronal growth was not reported.  A second surface modification technique utilized 
carboxy-endcapped polypyrrole for immobilizing RGD peptide.  Polypyrrole was first 
deposited onto a conductive glass slide, which was then transferred to a solution 
containing the carboxy-endcapped polypyrrole147.  RGD was attached to the polypyrrole 
by activating the carboxylic acids and reacting it with GRGDSP peptide.  The 
conductivity of RGD-modified polypyrrole was nearly equivalent to unmodified 
polypyrrole, but promoted 88% greater endothelial cell adhesion after 3 hours147.  
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Endothelial cells were utilized to gauge the general cell response to the bioactive cue; 
further investigation using neuronal cells are needed to assess its potential in nerve 
regeneration.  RGD has also been non-covalently attached to the polypyrrole.  Using a 
bacteriophage library, a phage clone (T59) that preferentially binds to polypyrrole was 
identified and synthesized with GRGDS.  The resulting polypyrrole-T59-GRGDS 
enhanced PC12 adhesion compared to substrate without GRGDS149, but was tested on 
primary neurons or in vivo.     
In addition to surface modification techniques, bulk incorporation of ECM-
derived components has been used to improve cell adhesion.  The laminin B1-derived 
peptide sequence YIGSR and the laminin B2-derived RNIAEIIKDI have been 
incorporated into polypyrrole. RNIAEIIKDI-modified polypyrrole displayed lower 
impedance and had higher neuron density than polypyrrole with YIGSR.  Compared to 
laminin, however, the highest neuron density observed on polypyrrole with any of its 
epitopes was still 3-fold lower184.  
Polysaccharide ECM components have also been combined with polypyrrole.  
Thin films of polypyrrole modified with hyaluronic acid were made with conductivity 
similar to polypyrrole which enabled PC12 neurite sprouting185.  Chitosan was mixed 
with different concentrations of polypyrrole in order to create porous, conducting 
scaffolds186.  Composites of higher conductivity could be created by adding more 
polypyrrole, with the maximum value being on the order of 10-1 S-cm-1.  This is 
approximately an order of magnitude lower than unmodified polypyrrole or the 
polypyrrole-hyaluronic acid composite185, demonstrating the challenge of creating a 
scaffold that is both conducting and bioactive.  
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To enhance the regeneration response, neurotrophic factors95,97,101 or 
dexamethasone187 have been co-polymerized with polypyrroles.  By adding growth 
factors during the electrodeposition process, films of polypyrrole with neurotrophin-3 and 
NGF were used to test the effect of electrical and growth factor stimulation on neurons.  
The amount of neurotrophin-3 loading was controllable through the polymerization time, 
while its release could be mediated by applying pulsed voltage, pulsed current, or cyclic 
voltammetry96.  Auditory neurons have been cultured on neurotrophin-3 containing 
polypyrroles, showing significantly greater neurite outgrowth than the unmodified 
polypyrrole surface97.  The diffusion of growth factors from the surface likely contributed 
to the improved sprouting response, since neurons not in direct contact with the 
neurotrophin-3 containing polypyrrole also grew equally well97.  Other growth factors 
may similarly diffuse from polypyrroles, supported by polypyrrole-collagen-NGF 
substrate improving neurite sprouting from PC12 cells compared to polypyrrole-collagen 
in vitro95. 
The combination of growth factor and electrical stimulation has been investigated 
by immobilizing NGF onto polypyrrole.  To improve neuronal growth, NGF has already 
been immobilized in non-conducting polymers98-100.  Similarly, NGF was conjugated to 
the surface of polypyrrole to assess the effects of an immobilized growth factor with 
electrical stimulation101.    An NGF concentration of 0.98 ng/mm2 was bound to 
polypyrrole surface and with electrical stimulation, this material increased neurite 
sprouting and extension from PC12 cells, an effect that was not due to NGF leaching 
from the surface.   
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Whereas most delivery approaches using polypyrrole involve growth factors, 
small molecule drugs can also be delivered.  Dexamethasone is a drug that reduces pro-
inflammatory cytokines188 and its binding to receptors mediates the inhibition of 
astrocyte proliferation and microglial activation189.  Controlled release of dexamethasone 
was mediated through incorporation into polypyrrole187.  To release the drug, the voltage 
was swept from -0.8 to 1.4 V at a scan rate of 100 mV/s, with one cycle releasing 0.5 
g/cm2, and by 30 cycles, 16 g/cm2.  The effect of the electrically-released 
dexamethasone on astrocyte number and neuronal viability was assessed and compared 
against cells treated with 10-6 M soluble dexamethasone.  Electrically-released drug did 
not affect neuronal viability but caused a significant decrease in astrocyte number, similar 
to the addition of dexamethasone.  This may have been caused by reduced astrocyte 
proliferation, but the potential mechanism was not reported.  This approach may help 
create a more growth-permissive environment by targeting cells that deposit the glial scar 
following CNS injury.  
 To change the permanent nature of polypyrroles, erodible and biodegradable 
polymers based on polypyrrole have been synthesized.  Non-biodegradable materials that 
remain in the body are likely to elicit continuing inflammation, and may also act as a 
physical barrier to the regeneration response.  Conducting polymers have been made that 
enable erosion and conductivity properties to be controlled.  -substituted polypyrrole 
monomers were electrochemically or chemically polymerized and showed in vitro 
biocompatibility by supporting the attachment and proliferation of mesenchymal 
progenitor cells190.  Erosion of the -substituted polypyrroles proceeded in a pH-
dependent manner and was controllable according to the co-polymer composition.  
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Tethering pyrrole-thiophene oligomers with degradable ester linkages191 also resulted in 
degradable, conducting polypyrroles.  Although the ester linkages enable hydrolysis of 
these polymers, the relatively short conducting oligomers might reduce the electrical 
conductivity of the material.   
 
1.5.5 Materials with Topographical Cues 
Physical contact with the ECM, cells, or synthetic substrates is known to direct 
cell growth and migration.  The organization of ECM fibrils are involved in the migration 
of neural crest cells192, while the parallel orientation of neuroblasts to glial fibers suggests 
contact-mediated cues193 in the developing nervous system.  The presence of radial glia194 
and pioneer axons195 in the brain influence neuron migration and process orientation.  In 
vitro196,197 and in vivo198 studies indicate that olfactory ensheathing cells and 
oligodendrocytes provide guidance cues to neurons.  Topographical features on polymers 
or inorganic compounds (gold, titanium, silicon, carbon, silica, lithium niobate, silicon 
nitride) can also provide guidance to a variety of cells, including mesenchymal cells, 
oligodendrocytes, neurons, and macrophages14.   
The mechanisms involved in axonal guidance are not fully understood.  Substrate 
adhesiveness15, shape16,17,  pattern dimensions, and the type and age of the neurons18-20 
influence growth cone motility and neurite alignment.  Research is aimed at identifying 
effective approaches for directing neurite growth.  The effects of contact guidance on 
nerve regeneration are being investigated through utilizing aligned channels or fibers in 
scaffolds, and in surface patterning techniques for promoting neurite extension and 
Schwann cell alignment.  
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1.5.5.1 Aligned Channels in Scaffolds 
Scaffolds with multiple channels have been created in an attempt to mimic the 
endoneurial structure for peripheral nerve repair and to provide topographical guidance 
for spinal cord regeneration.  Aligned channels promote the orientation of Schwann cells 
and encourage axonal extension.  Collagen scaffolds with longitudinally aligned channels 
have been made by unidirectional freezing199,200.  Scanning electron microscopy revealed 
the presence of 20 to 50 m channels passing through the length of the construct.  When 
seeded with dorsal root ganglia, Schwann cells infiltrated the channels and formed a 
columnar pattern likened to Bands of Bünger.  Schwann cells grew in close association 
with neurons199.  Implantation of linear channels within PLA foam scaffolds promoted 
Schwann cells to line the inner channels and co-localization of axons with the Schwann 
cells in vivo following spinal cord hemisection21.  No axons were seen in amorphous PLA 
foams.  In another study, PLA scaffolds pre-seeded with Schwann cells also resulted in 
the co-localization of axons with Schwann cells after implantation into a transected spinal 
cord22.  The presence of both topographical cues and Schwann cells, however, did not 
fully repair the spinal cord, as hindlimb locomotor function was still significantly 
impaired six weeks after implantation of the construct.  Agarose scaffolds containing 
aligned channels and BDNF have also been made by the unidirectional freezing 
method60. 
Scaffolds with multiple, aligned channels have also been fabricated via templating 
methods with stainless steel wires or fibers.  In this fabrication method, a solution of 
polymer is injected into a mold containing the wires or fibers, which are eventually 
extracted.  Agarose scaffolds with channel diameters of 200 m and 76% porosity have 
44 
been implanted after a 2 mm spinal cord lesion in rats24.  The templated agarose scaffolds 
promoted linear organization of axons compared to animals without scaffolds, and the 
inclusion of BDNF-secreting cells increased the presence of axons in such scaffolds24.  
Generating the templates for the agarose scaffolds involved a multi-step process of 
extruding polystyrene fibers in a matrix of PMMA, dissolving the PMMA matrix, 
immersing the polystyrene fibers in agarose, and subsequently dissolving the fibers.  
Peptide modified pHEMA scaffolds with aligned channels have also been made using 
similar methods.  Scaffold porosities ranged from 33 to 37% and were controlled by the 
number of channels, which ranged from 82 to 132 m in diameter26.  Stainless steel 
wires, ranging from 150 to 660-m diameter, have also been used to create PLGA201 and 
PLG25 scaffolds with multiple channels.  PLGA scaffolds contained 450 or 600 m-
diameter channels, had a wide range of pore sizes (unreported in the literature), and 
exhibited porosities ranging from 78.7 to 88.6%201.  PLG scaffolds could be fabricated to 
contain channels with diameters of 150 or 250 m at 50% porosity25.     
Micro-patterned channels have been incorporated into the lumen wall to 
maximize axonal density and maintain contact-guidance202.  A conduit of poly(D,L-
lactide) films with 20/20/3 m (channel width / spacing / depth) micro-patterns were 
implanted following a 10 mm sciatic nerve gap.  Micro-patterned conduits led to 
statistically significant enhancement in axonal myelination compared to un-patterned 
PLA conduits.  Micropatterned surfaces have also been used to promote Schwann cell 
and neuronal cell alignment in vitro (See ‘Surface Patterning for Promoting Neuronal 
Growth’ and ‘Surface Patterning for Glial Alignment’ below).   
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1.5.5.2 Aligned Fibers 
Electrospun fibers are desirable for nerve tissue engineering due to their high 
surface area to volume ratio that may be used to maximize neuronal attachment and 
growth.  Fiber orientation and size are important parameters for guiding cell growth.  
These fibers may be bundled or packed into a hollow conduit prior to being utilized as a 
nerve guide.  Fiber orientation affects neurite extension; aligned PLA fibers elicited 
parallel alignment of and significantly longer neurites than random fibers27.  There may 
be optimal fiber diameters that are best at eliciting longer and straighter neurite extension, 
but they are yet to be defined.       
Recent developments in electrospun fibers involve the incorporation of growth 
factors or ECM components into the polymer solution.  The resultant fibers can deliver 
bioactive molecules while providing a substrate that directs axonal extension to the target 
nerve.  A co-polymer of PCL and ethyl ethylene phosphate were co-spun with GDNF in 
solution, and nerve guides containing one of two different fiber alignments were 
implanted into a 15 mm sciatic nerve gap28.  The nerve guide channel was constructed by 
depositing fibers, having longitudinal or circumferential alignment, onto a film of PCL 
and ethyl ethylene phosphate, which was then rolled.  Total myelinated axons and axonal 
area were greatest in rats that received scaffolds with longitudinally-aligned fibers and 
BDNF, compared to scaffolds that contained longitudinal or circumferential alignment 
without BDNF.  Rats which received GDNF-containing fibers were the only group to 
show significant functional improvement compared to the hollow nerve guide.  
Compound motor action potential recordings, howeer, indicate that recovery is still 
incomplete compared to the normal nerve28.  It was unclear whether the longitudinally 
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aligned fibers were critical for functional improvement, since circumferentially aligned 
fibers containing BDNF were not tested.  
An additional approach may be to incorporate ECM-derived components.  A 
blend of electrospun PCL and collagen nanofibers induced better guidance of Schwann 
cells than PCL-only scaffold, but did not affect the neurite length even when neurites 
grew on the Schwann cells29.  A close association between Schwann cells, neurites, and 
fibers was observed, but had little effect on the neurite length even for the neurites on the 
Schwann cells.  While topographical cues presented in the material and Schwann cell 
appears to direct axonal growth, additional bioactive cues might be needed to enhance the 
rate of regeneration.            
In addition to electrospinning, aligned fibers have been fabricated by melt 
extrusion and have been induced through magnetic alignment.  The effect of fiber 
curvature on neuronal alignment has been tested using melt-extruded polypropylene 
fibers30.  Neurons were cultured onto fibers ranging from 7 to 500 m in diameter.  
Neurite outgrowth became more aligned as the diameter became smaller, whereby 
alignment was always observed at the diameters from 7 to 10 m30.  Magnetic alignment 
may also be used to produce aligned fibers.  Magnetically aligned collagen fibrils were 
created by inducing fibrillogenesis within a 9.4 T magnetic field31.  Either aligned or non-
aligned collagen fibrils filled a collagen nerve guide, which was then implanted into a 6 
mm mouse sciatic nerve gap.  Nerve guides with aligned fibrils had significantly higher 
nerve cross-sectional area and myelinated fibers than non-aligned collagen.  These results 
support the role of contact guidance in sciatic nerve regeneration.  Further investigation is 
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necessary to identify the mechanisms and understand how cells (neurons, astrocytes, or 
non-neural) respond to topographical cues to improve regeneration. 
 
1.5.5.3 Surface Patterning for Promoting Neuronal Growth 
Topographical cues have been shown to guide neurite sprouting 18,33.  Different 
surface morphologies have been created in order to identify critical parameters that can 
guide and promote neurite growth.  The effects of the type and dimensions of the 
topographical cues on neuronal responses have been investigated using micro-fabrication 
techniques that allow precise control over surface features.  The two types of surface cues 
reviewed here include pillars and aligned channels, the latter of which is more commonly 
examined.    
Photolithography was used to produce 1 m-high pillars of varying widths and 
spacing to assess their effects on hippocampal neurons32.  Three different gap spaces 
ranging from 1.5 to 4.5 m, and two pillar widths (1 and 2 m) were tested.  The 2 m-
wide and 1.5 m-spaced pillars best enhanced the alignment and extension of neurites 
among the dimensions tested.  These dimensions promoted neurite extension along a 
straight path for some distance.  The presence of gaps between pillars, however, also 
allowed neurites to turn at ninety degree angles and continue along a new route.   
Parallel channels have been fabricated in an attempt to induce polarization and 
maintain neurite alignment toward a preferred direction18,33-35.  Using electron beam 
lithography, 1 and 2 m-wide channels of 50 to 2000 nm depths have been created with 
polypyrrole33.  Although patterning led to a significant increase in the polarization of 
neurites emanating from hippocampal neurons, the direction of neurite extension was 
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again either parallel or perpendicular to the channels.  The findings of studies utilizing 
pillar-modified32 and aligned microchannels18,33 appear to support the idea that channels 
of less than 2 m width allow perpendicular extension of neurites from hippocampal 
neurons.  Alternatively, the feature size may not be sufficient to overcome the surface 
chemistry, which was isotropic in these cases.  Furthermore, the dimensions that permit 
topographical guidance may vary among neuronal cell types.   
Considering the effects of cell-type and the dimensions of surface patterns on the 
alignment and length of neurites may prove useful in determining effective approaches 
for nerve regeneration.  Because different sizes of growth cones may have varying 
abilities to sense topographical changes, channel dimensions that effectively promote 
neurite alignment are likely to depend on the size of the neurites.  In a study utilizing 
mouse sympathetic and sensory ganglia, channel widths of 200 nm were effective at 
promoting parallel axonal orientation.  Researchers reported that the ability of axons to 
align to parallel channels appeared to be related to the diameter of axons34.  In addition to 
the importance of channel spacing in contact guidance, the width of the ridges also 
appears to be a relevant variable.  Narrower groove spacing on PCL promoted better 
neurite alignment from embryonic cortex neurons35.  Neurites grew perpendicular to 12.7 
m groove spacing and 4.3 m ridge width; they extended parallel neurites to the 
narrower groove spacing of 6.1 and 8.4 m, and ridge spacing of 2.2 and 3.6 m35.  In 
another study, better alignment of sensory and sympathetic ganglia neurites was observed 
when the ridge width was decreased while holding the channel width constant, but only 
when the channel width was 200 nm or less34. 
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Micropatterned surfaces have also been investigated in the differentiation of 
progenitor cells.  Co-culturing astrocytes and adult rat hippocampal progenitor cells on a 
micro-patterned surface significantly increased the expression of a neuron-specific 
marker, from 15.3% to 35.3%203.  The presence of astrocytes did not affect expression of 
the neuron-specific marker when co-cultured on planar surfaces203, which suggests that 
topographical cues played a role in differentiation.  Further investigations are needed to 
determine whether the surface patterning affects neurons directly or the effects are 
mediated by astrocytes. 
Depositing bioactive cues in select locations and imprinting patterns of different 
topographies may be combined to produce micro-patterned surfaces with cell-adhesive 
domains183 or immobilized growth factors98.  Polypyrrole was modified with 
polyglutamic acid to permit the conjugation of laminin and polylysine.  Select 
electrodeposition of polypyrrole by photolithography, followed by modification with the 
bioactive cues, permitted the selective attachment of dorsal root ganglia183.  Another 
study examined the contribution of topography and NGF immobilization on the 
polarization and extension of hippocampal neurons.  Poly(dimethyl siloxane) 
microchannels of 1 to 2 m widths were made, which were subsequently conjugated with 
NGF.  Polarization was more significantly affected by the presence of microchannels 
rather than 0.1 ng/mm2 of NGF on the surface, whereas neurite length was increased in a 
synergistic manner when both NGF and microtopography were presented98.  Neuronal 
responses, therefore, can be modulated by the presence of topographical cues presented 
as patterned surfaces. 
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1.5.5.4 Surface Patterning for Glial Alignment 
Topographies that promote the alignment of Schwann cells or mimic their 
surfaces have been investigated.  Following peripheral injury, Bands of Bünger 
consisting of columnar Schwann cells form and promote axonal migration along its 
surface204.  Re-creating this orientation of Schwann cells may be useful in eliciting axonal 
regeneration after nerve injury.  The physical topography of Schwann cells has been 
investigated by creating a cell-free surface that mimics its micro- and nano-scale 
features205.  After using microfabricated laminin pattern to align Schwann cells, cells 
were fixed and sputter-coated with gold.  A negative imprint of the surface was made 
onto a PDMS template, which was then used to fabricate a biomimetic substrate 
containing the cell impressions.  The biomimetic surface promoted significantly greater 
adhesion of dorsal root ganglia and supported the alignment of neurons and Schwann 
cells205.   
Selectively modifying areas to be cell-adhesive has been used to induce Schwann 
cell alignment.  Micro-patterning of laminin onto PLA206 and PMMA207 induced the 
alignment of Schwann cells on these surfaces.  In the study utilizing PLA, compression 
molding was used to produce polymer films with grooves that adsorbed a higher 
concentration of laminin within them 206.  In the later study using PMMA, laminin was 
adsorbed onto the polymer by a PDMS stamp which created parallel lines of the protein, 
spaced at various distances.  Smaller pattern widths increased the alignment of Schwann 
cells, regardless of interval width207.  In both studies, the patterning of an ECM 
component that contains several adhesion-promoting domains promoted Schwann cells to 
adhere in a columnar manner206,207.  Schwann cells aligned; however, it was difficult to 
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assess whether the orientation was caused by the surface topography or the selective 
deposition of cell adhesive material.  Further investigation is needed to decouple the two.  
   The dimensional variables of channel width, spacing, and depth have been found 
to affect Schwann cell responses.  Silicon chips with microgrooves ranging from 2 to 100 
m widths were created and coated with poly-D-lysine and laminin204.  Sixty percent of 
Schwann cells aligned to the microgrooves of 50 and 100 m widths; 90% oriented 
themselves parallel when the lanes were between 2 and 20 m wide.  Furthermore, dorsal 
root ganglia also extended aligned neurites to the patterned surfaces that had been pre-
seeded with Schwann cells.  A similar effect of groove dimensions on cell alignment was 
observed in a separate study using PCL coated with poly-L-lysine.  In this investigation, 
astrocytes aligned to grooves that were spaced at 12.5 m and 25 m, but exhibited less 
parallel orientation at larger grooves of 50 to 100 m208 (Figure 1.3).  Grooves spaced 
less than 25 m apart were more effective at promoting parallel alignment of astrocytes 
and neurites.  Neurons cultured on aligned astrocytes survived longer than those grown 
on the patterned polymer, and extended parallel neurites corresponding to the underlying 
topography for up to 3 weeks208.  Spinal cord neurons sensed the microgrooves 
underneath astrocytes, and responded by extending and maintaining neurites parallel to 
the underlying surface.  However, the alignment decreased over time, likely due to the 
increased proliferation of astrocytes.  These studies indicate that groove widths are 
important.  Groove depth has been shown to be significant in promoting alignment as 
well; changing it from 0.5 m to 1.5 m induced a significant increase in Schwann cell 
alignment209.  Micro-channels, therefore, can affect the morphology of neurons even 
when Schwann cells or astrocytes are the cells in direct contact with them.   
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The potential of micro-patterned surfaces in improving the regenerative response 
has been demonstrated in a peripheral nerve injury model.  PLA film was modified with 
aligned channels using solvent casting, and rolled into a cylindrical conduit for 
implantation into a 10 mm sciatic nerve gap in rats.  Six weeks later, grooved constructs 
exhibited significantly greater axonal area, myelination, and angiogenesis than smooth 
scaffolds202.  Culturing Schwann cells onto chitosan led to significantly less NGF and 
BDNF expression compared to PLA202, indicating that different surface chemistries also 
impact cell response.  The influence of topological guidance in vivo still needs to be 
examined in the regeneration of larger peripheral nerve gaps (20 mm or greater) to 
determine its efficacy in peripheral nerve regeneration.  It may also be useful in 
promoting regeneration in the spinal cord, using contact guidance alone or in 
combination with Schwann cells or olfactory ensheathing glial cells.   
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Figure 1.3.  Aligned neurite extension on microgrooved substrates that have been 
preseeded with aligned astrocytes (A) or coated with poly-L-lysine (B).  Three-
dimensional projection created from confocal z-stack images.  A) The astrocyte-specific 
marker GFAP (red) labels the underlying astrocyte layer, while neurons are labeled by 
Tuj1 (green).  B) Microgrooves were imaged by reflection of the laser line (red).  
Arrowheads illustrate grooves208. 
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Chapter 2. SYNTHESIS OF NEW POLYMERS 
 
2.1 Neurotransmitters and their roles 
 
Neurotransmitters are chemical messengers that propagate the transmission of 
electrical signals and also influence survival, proliferation, process extension, and 
differentiation in the nervous system.  The effects of neurotransmitters on the developing 
central nervous system have been thoroughly covered in recent reviews9,210,211, and some 
are briefly described here.  GABA administration attenuates the cytotoxicity of glutamate 
in combination with an anti-convulsant8; GABA-induced proliferation of neuroblasts has 
also been observed9.  In the developing brain, the activation of dopamine receptors 
affects proliferation and differentiation of progenitor cells212,213.  Glycine mediates 
dendritic branching while acetylcholine exerts a chemoattractant influence on embryonic 
nerve growth cones9.  The effects of these neurotransmitters on the cell response may 
depend on the developmental stage12 and the type214,215 of neuron that is being studied.  
The developmental stage and type of neuron used to evaluate the effects of 
neurotransmitters in nerve repair is an important consideration, as most nerve injuries 
requiring treatment occur in adults.   
Acetylcholine regulates neuronal cytoarchitecture in embryonic and adult neurons 
and imparts neuroprotection.  The activation of acetylcholine receptors induces neurite 
outgrowth216-218 and promotes the formation and strengthening of synapses11,12.  
Acetylcholine-mediated axonal growth is believed to occur via an increase in intracellular 
calcium level219, which likely initiates intracellular signaling events.  Stimulating 
acetylcholine receptors triggers the influx of extracellular calcium and activates specific 
gene transcriptions including actin220, which plays a key role in axon extension.  Local 
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application of acetylcholine induces the nerve growth cone to turn toward the 
acetylcholine gradient10.  In addition to its effect on process extension, acetylcholine may 
also be involved in pathfinding during synapse formation, as suggested by its 
spontaneous release from embryonic neurons221.  The stimulation of nicotinic 
acetylcholine receptors elicits improved behavioral performance in rats and monkeys, and 
appears to be mediated by the expression of FGF-2214.  Exposure to nicotine, an 
acetylcholine agonist, activates the ERK1/2 signaling pathway to protect against the 
apoptosis of spinal cord neurons isolated from 13-day old mice222.  Muscarinic receptor 
activation also protects neuroblastoma cells from DNA damage, oxidative stress, and 
mitochondrial impairment223.  Acetylcholine’s role in regulating neuronal development, 
growth, and survival makes it a potential candidate for use in eliciting and directing nerve 
regeneration after injury. 
In addition to mediating neuronal responses, neurotransmitters can also affect 
astrocytes and oligodendrocytes by changing the expression of neurotransmitter receptors 
expressed on their surface or stimulating their migration224-226.  Neurotransmitter 
stimulation of glial cells promotes neuronal growth, as shown in vitro by the improved 
growth of neurons in response to conditioned media derived from serotonin-stimulated 
astrocytes227.   
 
2.2 Rationale for acetylcholine-based materials in nerve repair 
 
Because neurotransmitters play important roles in neural cell activities, 
neurotransmitter-based materials may be useful.  Surface-tethered neurotransmitters228,229 
were shown to activate the corresponding cellular receptors.  Dopamine integrated into a 
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biodegradable polymer has been used to investigate cell recognition and responses13.  We 
hypothesize that acetylcholine-based materials may also be used to promote neurite 
sprouting and extension.   We devise a modular design that enables acetylcholine-like 
motifs to be incorporated within the polymer and control over its concentration.  Leucine 
ethyl ester, having no known specific interaction with neurons, was included in the 
polymerization to control incorporation of the amount of acetylcholine-like motifs.  The 
polymers are designed to be biodegradable by hydrolysis and possess a flexible polymer 
backbone to allow presentation of the neurotransmitter motif as a side chain.   
 
2.3 Materials and methods for monomer and polymer synthesis 
2.3.1 Diglycidyl sebacate was synthesized by one of two methods: by 
transesterification of diethyl sebacate (Figure 2.1) or by oxidation of diallyl sebacate 
(Figure 2.2).  Freshly distilled glycidol (Acros, Geel, Belgium) dried with molecular 
sieves was refluxed with diethyl sebacate (Acros, Geel, Belgium) in the presence of 
thallium acetate catalyst (Alfa Aesar, Ward Hill, MA).  The following parameters in the 
transesterification reaction were varied in to maximize the production of diglycidyl 
sebacate: molar ratios of glycidol and thallium acetate to diethyl sebacate, temperature 
(55 vs. 110°C), and pressure (60 to 80 torr).  The formation of diglycidyl sebacate was 
monitored by thin layer chromatography.   
For the oxidization reaction, diallyl alcohol was first synthesized by refluxing 
allyl alcohol (20.0 g, 0.100 mole, Alfa Aesar, Ward Hill, MA) and sebacic acid (53.7 ml, 
0.800 mole, Alfa Aesar, Ward Hill, MA) at 105°C in 0.1% (v/v) sulfuric acid for 24 
hours.  Excess sulfuric acid was neutralized with sodium carbonate and unreacted allyl 
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alcohol was evaporated off at 70°C for 1 hour under vacuum.  The product, diallyl 
sebacate, was extracted with ethyl acetate and dried with anhydrous Na2SO4.  Diallyl 
sebacate was oxidized by m-chloroperoxybenzoic  acid (mCPBA) (70-75% purity, Acros 
Organics, Geel, Belgium) in methylene chloride refluxed at 40 °C for 8 hours to produce 
diglycidyl sebacate monomer.  The byproduct m-chlorobenzoic acid was crystallized at -
20 °C overnight and filtered from the solution.  The remaining chlorobenzoic acid in 
solution was removed by buffer extraction or by ionic resin.   In the buffer extraction 
method, remaining acid in solution was neutralized by an aqueous solution of Na2CO3 / 
NaHCO3 (100 ml de-ionized water, 7.69 g Na2CO3, 2.86 g NaHCO3), followed by 
extraction of diglycidyl sebacate using ethyl acetate at 4:1 (v/v) ratio of buffer to ethyl 
acetate.  Chlorobenzoic acid was removed by ionic resin by passing the crude product 
through an ion exchange column.  Afterwards, pure diglycidyl sebacate was isolated by 
flash chromatography (Buchi Sepacore Flash, Flawil, Switzerland) in a mixture of ethyl 
acetate and hexane (3:7) on a silica gel column.  Separations of crude product less than 
400 mg utilized a 12 mm x 150 mm silica column, while separations for up to 1 g of 
product used a 40 mm x 150 mm silica column.  The purity of the final product was 
characterized using nuclear magnetic resonance spectroscopy (NMR) on a 400-MHz 
Mercury-400 NMR from Varian, Inc. (Palo Alto, CA).   
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2.3.2 Liberation of Amines.  Aminoethyl acetate was synthesized according to a 
published procedure,230 except the reaction flask containing ethanolamine hydrochloride 
and acetic acid were cooled in ice-water prior to the addition of acetyl chloride.  
Additionally, 2:1 molar ratio of acetyl chloride to ethanolamine hydrochloride was used.  
Aminoethyl acetate hydrochloride salt was liberated by one of the following methods: 1) 
precipitation by using triethylamine; 2) liberation by a solution of NaOH; and 3) 
dissolving in a basic sodium carbonate-bicarbonate buffer, followed by extraction with 
ethyl acetate.  In the first method, 1 mole of triethylamine was combined with 1 mole of 
aminoethyl acetate hydrochloride in methanol.  The second method also utilized 1 mole 
of aqueous NaOH (1 ml) to 1 mole of aminoethyl acetate hydrochloride (100 mg), 
 
 
Figure 2.1.  Transesterification of diethyl sebacate with glycidol for synthesizing 
diglycidyl sebacate. 
 
 
 
Figure 2.2.  Synthesis of diglycidyl sebacate by oxidizing diallyl sebacate. 
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followed by extraction with ethyl acetate (20 ml).  The third method used one of two 
Na2CO3 / NaHCO3 buffers, one at pH 9.7 (100 mg Na2CO3, 11 mg NaHCO3, 10 ml de-
ionized water) and the other at pH 10.5 (502.6 mg Na2CO3, 77.6 mg NaHCO3, 5 ml de-
ionized water).  The salt was dissolved in the buffer at concentrations ranging from 0.1 to 
2.3 grams of aminoethyl acetate hydrochloride salt per 1 ml of buffer, and the aminoethyl 
acetate was extracted with ethyl acetate at 2 to 200-fold excess over the volume of buffer 
used. 
Leucine ethyl ester hydrochloride (TCI America, Portland, OR) was similarly 
liberated using a sodium carbonate-bicarbonate buffer.  In addition the two buffers 
mentioned above, a pH 13.0 buffer was also used (3545.29 mg Na2CO3, 54.68 mg 
NaHCO3, 10 ml de-ionized water).  Leucine ethyl ester hydrochloride was dissolved in 
the buffers at concentrations ranging from 0.1 to 2.0 grams of salt per 1 ml of buffer, and 
the leucine ethyl ester was extracted with ethyl acetate at 2 to 200-fold excess over the 
volume of buffer used.   
 
2.3.3 Polymer Synthesis 
Diglycidyl sebacate, with equimolar Mg(ClO4)2, appropriate amounts of leucine ethyl 
ester and aminoethyl acetate were dissolved in DMF and stirred under N2 at 90 °C.  The 
amounts of leucine ethyl ester and aminoethyl acetate were adjusted accordingly to 
synthesize the following polymers: PSA100L0, PSA70L30, PSA40L60, PSA0L100 (Ax = % 
acetylcholine, L1-x = % leucine ethyl ester) (Figure 2.3).  The reaction mixture was 
heated at 90 °C for 5 days, and any remaining DMF in the resultant viscous liquid was 
removed with vacuum of 400 mTorr.  Ethanol was added to re-dissolve the polymer and 
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evaporated to hasten removal of DMF.  Polymers were precipitated in water and ethyl 
acetate to remove unreacted monomers and dried.  NMR spectra were recorded on a 400-
MHz Mercury-400 NMR from Varian, Inc. (Palo Alto, CA).  FTIR spectra were recorded 
on an IR-100 spectrometer from Thermo Nicolet (Waltham, MA).  Differential scanning 
calorimetry was performed on a DSC Q100 from TA Instruments (New Castle, DE).  The 
molecular weights of the polymers were determined using gel permeation 
chromatography using standard or universal calibration.  For standard calibration, poly-
styrene standards were eluted on a 60 Å YMC-Pack aqueous gel permeation 
chromatography column connected to a Waters 2690 separations module and Waters 
2410 refractive index detector (Milford, MA).  For universal calibration, a universally 
calibrated polystyrene standard was eluted on a Viscotek RImax system connected to a 
Model 3580 Refractive Index Detector, GPCmax™ Integrated 
Pump/Autosampler/Degasser Module, and Model 270 Differential Viscometer/Low 
Angle Light Scattering Dual Detector (Houston, TX). 
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2.4 Materials Characterization 
2.4.1 Diglycidyl Sebacate.  Products from the oxidation of diallyl sebacate were 
visualized after thin layer chromatography by using a ceric molybdate stain, revealing 
dark blue spots corresponding to the monoglycidyl sebacate, diglycidyl sebacate, and un-
identified by-products of the reaction.  The retention factor, the fraction of the total 
solvent distance traveled by a product, of the diglycidyl sebacate was 0.31.   
Diglycidyl sebacate was first synthesized by transesterification (Table 2.1).  
Transesterification synthesis led to a maximum yield of 34%, a yield which was 
negatively affected by the formation of a clear, insoluble, gel-like by-product.  Reaction 
conditions that were initially chosen did not yield any diglycidyl sebacate (Condition #1).  
Decreasing the molar ratio of glycidol from 3.6 to 2.4 and lowering the pressure to 
facilitate ethanol evaporation improved the yield to 14% (Condition #2).  The glycidol 
Figure 2.3. Polycondensation of the desired amount of leucine ethyl ester and 
aminoethyl acetate with diglycidyl sebacate results in biomaterials with varying 
amounts of acetylcholine motifs.  The acetylcholine motif is circled and the 
structure of acetylcholine is shown for comparison. 
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and diglycidyl ester appeared to undergo a side reaction, forming the insoluble gel-like 
by-product.  To minimize by-product formation, the reaction time and temperature were 
decreased to 55°C and 7 hour, increasing the yield to 27% (Condition #3).  The 
temperature was lowered in order to slow the kinetics of by-product formation, but 
maintained at a level that would permit diglycidyl synthesis.  Because an increased yield 
resulted from lower reaction time and temperature, it was hypothesized that the high 
temperature favored by-product formation.  The reaction temperature was maintained at 
55°C, while the molar ratio of glycidol and reaction time was increased to drive 
formation of diglycidyl sebacate while retarding by-product formation.  Performing the 
transesterification reaction at 4.8:1 molar excess of glycidol to diethyl sebacate at 55°C 
for 24 hours resulted in 34% yield (Condition #4).  The lower temperature and increased 
availability of glycidol contributed to an improved yield. 
Table 2.1. Purified yields of diglycidyl sebacate by transesterification.   
 Molar Ratio  
Condition Diethyl 
Sebacate 
Glycidol Time 
(hr) 
Temperature 
(°C) 
Pressue 
(Torr) 
Purified 
Yield 
1 1 3.6 13 110 80 0 % 
2 1 2.4 14 110 60 14 % 
3 1 2.4 7 55 60 27 % 
4 1 4.8 24 55 60 34 % 
 
 Diglycidyl sebacate was also synthesized by the oxidation of diallyl sebacate.  
Synthesis yield was greater than 90%, assessed by NMR of the crude product 
immediately following the reaction.  The purity of the mCPBA and the separations 
processes significantly affected the yield of purified diglycidyl sebacate (Table 2.2).  
Oxidizing diallyl sebacate for 6 hours at 40 °C with a 3:1 molar ratio of mCPBA to 
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diallyl sebacate resulted in yields of 77% and 91%.  Using lower purity of mCPBA 
negatively affected the yield, where yield of 47% was obtained.  The molar ratio of 
mCPBA to diallyl sebacate was kept constant between conditions 1 and 2.  Because 
mCPBA is commercially available only as a mixture of peroxy and reduced acids, a 
lower purity product required more of the oxidizing mixture to be added to compensate 
for the difference in purity.  The higher amount of the chlorobenzoic acid likely caused 
degradation of diglycidyl sebacate when mCPBA extraction by sodium carbonate - 
sodium bicarbonate buffer was performed.  
The separations method used to extract mCPBA and by-products affected the 
purified yields.  To prevent degradation of the ester by acid hydrolysis, chlorobenzoic 
acid was separated from the reaction mixture by ionic resin extraction instead of 
extraction by sodium carbonate-sodium bicarbonate buffer.  Utilizing ionic resin resulted 
in an increased yield from 47% to roughly 60% (Condition #3).  mCPBA extraction by 
ionic resin minimized the exposure of diglycidyl sebacate to water, unlike the buffer 
extraction method that likely cleaved the ester linkage by hydrolysis.  Following mCPBA 
extraction, pure diglycidyl sebacate was isolated from by-products using normal phase, 
liquid chromatography.  Conditions 1-3 utilized a smaller silica column, capable of 
separating up to 400 mg of crude product.  During the attempt to scale up the synthesis 
and purification of diglycidyl sebacate, a larger silica column was used to separate up to 1 
g of crude product.  Using a larger silica column decreased yield to 22% to 30% 
(Condition #4), which likely was due to degradation on the larger column.  Degradation 
was confirmed by the additional presence of by-products which had not appeared prior to 
liquid chromatography separation. 
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Table 2.2. Purified yields of diglycidyl sebacate by oxidation reaction.  * indicates a 
batch of lower purity mCPBA was used. 
Condition Diallyl 
Sebacate 
mCPBA Time 
(hr) 
Temperature 
(°C) 
Separations 
Process 
Purified 
Yield 
1 1 3 6 40 mCPBA 
extraction by 
buffer 
77% 
91% 
2 1 3* 6 40 mCPBA 
extraction by 
buffer 
47% 
 
3 1 3* 6 40 mCPBA 
extraction by 
ionic resin 
60% 
65% 
65% 
4 1 3* 6 40 Larger scale 
separation by 
liquid 
chromato- 
graphy 
22% 
30% 
 
1H NMR spectrum of digylcydiyl sebacate in chloroform-d: δ 4.40 (m, 2H), 3.90 
(m, 2H), 3.20 (m, 2H), 2.84 (t, 2H), 2.64 (m, 2H), 2.34 (t, 4H), 1.63 (t, 4H), 1.30 (s, 8H), 
(Figure 2.4).
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Figure 2.4. NMR spectrum of diglycidyl sebacate.  
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2.4.2 Liberated aminoethyl acetate and leucine ethyl ester were clear liquids at room 
temperature, compared to white crystalline powder in their unliberated states.  A 
summary of conditions for liberating the amine monomers are listed in Tables 2.3 and 
2.4.  Using sodium carbonate-sodium bicarbonate (Na2CO3/NaHCO3) buffer was most 
effective for liberating both amine monomers.   
The ratio of ethyl acetate to buffer was the most influential factor for isolating 
high yields of aminoethyl acetate.  Approximately 83% of aminoethyl acetate’s 
theoretical yield was isolated using a pH 10.5 buffer and a 200:1 (v/v) ratio of ethyl 
acetate to the buffer.  The high ratio of organic solvent to buffer is necessary because of 
aminoethyl acetate’s solubility in water, while the pH 10.5 buffer with sufficient 
buffering capacity maintained aminoethyl acetate in its liberated state.  1H NMR of 
aminoethyl acetate in chloroform-d: δ 3.69 (t, 2H), 3.39 (m, 2H), 2.00 (s, 3H), (Figure 
2.5).   
The pH of the organic solvent to buffer affected isolation yields for leucine ethyl 
ester.  A pH 10.5 buffer was sufficient at isolating leucine ethyl ester at 60% and 71% 
yields at ethyl acetate to buffer ratio of 20 to 1.  Increasing the pH of the buffer to 13.0 
improved the yields to 81% and 82%.  Leucine ethyl ester’s solubility in water is less 
than that of aminoethyl acetate due to the presence of the isopropyl group.  Leucine ethyl 
ester was isolated at similar yield to aminoethyl acetate using lower ratios of ethyl acetate 
to buffer.  Leucine ethyl ester was distilled after liberation at 120°C and 72 torr.  1H 
NMR for leucine ethyl ester in chloroform-d: δ 4.16 (m, 2H), 3.44 (m, 1H), 1.77 (m, 1H), 
1.48 (m, 2H), 1.27 (t, 3H), 0.92 (t, 6H), (Figure 2.6). 
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Table 2.3.  Isolated yields of aminoethyl acetate. 
Liberation method pH of 
Na2CO3/NaHCO3 
buffer 
Ethyl Acetate : 
Buffer (vol/vol) 
Isolated Yield 
Precipitation by 
triethylamine 
n/a n/a 0% 
Aqueous NaOH 14.0 20:1 2% 
Na2CO3/NaHCO3 
buffer #1 
9.7 2:1 0% 
Na2CO3/NaHCO3 
buffer #2 
10.5 5:1 8% 
Na2CO3/NaHCO3 
buffer #2 
10.5 50:1 68% 
Na2CO3/NaHCO3 
buffer #2 
10.5 200:1 86%, 80%, 
84% 
 
 
 
 
Figure 2.5.  NMR spectrum of aminoethyl acetate. 
68 
 Table 2.4. Isolated yields of leucine ethyl ester. 
pH of Na2CO3/NaHCO3 
buffer 
Ethyl Acetate : Buffer 
(vol/vol) 
Isolated Yield 
9.7 2:1 0 % 
10.5 20:1 60%, 71% 
13.0 20:1 81%, 82% 
 
 
 
Figure 2.6. NMR spectrum of leucine ethyl ester. 
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2.4.3 Polymers containing different concentrations of acetylcholine motif.  After 
removal of DMF and unreacted monomers, most polymers were isolated at 
approximately 25% yield (Table 2.5).  The summary of polymer yields is not listed in 
any particular order, except for increasing concentration of acetylcholine motif.  The 
primary goal of polymer synthesis was to obtain sufficient amount of polymer for in vitro 
evaluation, with a secondary goal of maximizing polymer yield.  Future optimization 
studies could be performed by testing each process variable may be tested at two levels 
(low vs. high value) to identify trends and potential interactive effects.  Assuming that 
three variables (concentration, time, and temperature) are to be tested at two values, 
optimization would require 8 experiments per acetylcholine motif concentration, and 40 
total experiments for 5 concentrations.   
Due to time constraints, optimization studies were not performed.  The results 
presented here may highlight potential trends for optimizing polymer yield.  For example, 
when synthesizing polymers having the same acetylcholine motif concentration, 
increasing both the concentration and the duration of the reaction appeared to increase 
yield.  When synthesizing PSA0L100 at 90°C, increasing the concentration of reactants 
from 300 to 1100 mg/ml and lengthening the reaction time from 4 to 6 days led to a 56% 
increase in purified yield (Reactions 1 and 2).     
Identifying optimal polymerization conditions that are applicable to the synthesis 
of all polymers are difficult, since such conditions are likely to be specific to polymer 
composition.  Yield may also depend on the polymer type; utilizing identical reaction 
conditions for two different polymer types result in different yields.  Obtaining high yield 
is important in order to obtain sufficient amounts of the material; however it is also 
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important to preserve the polymer’s properties that are useful for its application.  For 
example, highly concentrating the monomers during the polymerization may lead to high 
yield, but the resulting polymer may be more cross-linked.  Although a higher yield may 
be achieved, changing this polymer property could affect cellular responses to the 
polymer by affecting the presentation of the acetylcholine motifs.   
The polymers’ compositions were determined using standard analytical methods.  
The content of acetylcholine motifs in each polymer was evaluated by comparing NMR 
peak integrations corresponding to the isopropyl group of leucine ethyl ester at δ 0.84 to 
the ethylene groups of sebacate at δ 1.23 (Figure 2.7).  Once polymerized, these peaks 
shifted slightly from the corresponding positions in the monomers.  The area ratios 
corresponding to PSA0L100 were determined for three different batches of the polymer 
and these averaged to provide an empirically-derived baseline value.  Table 2.6 provides 
the corresponding leucine ethyl ester and acetylcholine motif concentrations, and lists the 
polymer designation for each polymer. 
Fourier transformed infrared (FTIR) spectra of the bulk polymers revealed an 
intense C=O stretch at 1725 cm-1, confirming the presence of ester bonds along the 
backbone of the polymer.  The subsequent peaks at 1650 cm-1 and 1557 cm-1 are shifts in 
the C=O stretch due to hydrogen bonding within the polymer.  Polymers containing the 
acetylcholine motif also indicated the presence of the acetate ester C-O bond at 1241 cm-1 
and confirmed the incorporation of aminoethyl acetate in polymers containing the 
acetylcholine motif (Figure 2.8).   
71 
Table 2.5. Summary of polymerization yields. 
Reaction Polymer Concentration 
(mg diglycidyl/ 
ml solvent) 
Time 
(days) 
Temperature 
(°C) 
Purified 
Yield 
1 PSA0L100 300 4 90 15% 
2 PSA0L100 1100 6 90 71% 
3 PSA40L60 300 3 90 25% 
4 PSA60L40 300 4 90 23% 
5 PSA60L40 1600 11 60 30% 
6 PSA70L30 300 6 90 26% 
7 PSA70L30 1100 6 90 23% 
8 PSA100L0 300 6 90 33% 
 
72 
 
Table 2.6. Acetylcholine contents of polymers were empirically derived according to 
ratios of the areas corresponding to the isopropyl and ethylene groups at 0.84 and 1.23 
ppm, respectively. 
Area of peak 
associated with     
0.84 ppm 
1.23 
ppm Area Ratio 
Calculated 
Leu% 
Calculated 
Ach motif% 
Polymer 
Designation 
15.18 22.35 0.679195 101.7% -1.7% PSA0L100 
15.96 23.51 0.67886 101.6% -1.6% PSA0L100 
17.11 26.49 0.645904 96.7% 3.3% PSA0L100 
12.02 23.26 0.516767 77.4% 22.6% PSA20L80 
9.02 23.22 0.388458 58.2% 41.8% PSA40L60 
6.95 27.02 0.257217 38.5% 61.5% PSA60L40 
4.46 19.38 0.230134 34.5% 65.5% PSA70L30 
5.12 23.68 0.216216 32.4% 67.6% PSA70L30 
4.22 22.26 0.189578 28.4% 71.6% PSA70L30 
1.73 9.31 0.185822 27.8% 72.2% PSA70L30 
3.55 24.1 0.147303 22.1% 77.9% PSA80L20 
1.96 15.18 0.129117 19.3% 80.7% PSA80L20 
0 22.39 0 0.0% 100.0% PSA100L0 
0 25.06 0 0.0% 100.0% PSA100L0 
0 10.56 0 0.0% 100.0% PSA100L0 
 
Figure 2.7.  NMR characterization of polymers.  NMR spectrum of PSA70L30 with 
the isopropyl group of leucine ethyl ester at δ 0.84 (*) and the ethylene groups of 
sebacate at δ 1.23 (#).   
* 
# 
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The polymers’ molecular weights and glass transition temperatures (Tg) are reported in 
Table 2.6.  Tg values were not reported for all polymers analyzed by GPC due to limited 
availability of the polymers.  The polymer containing only acetylcholine motifs 
(PSA100L0) exhibited lower molecular weight and the lowest Tg than all other polymers.  
The acetylcholine motifs or undetectable impurities contained in aminoethyl acetate may 
have acted as plasticizers to lower the Tg of polymers having more motifs.  All of the 
polymers were soluble in DMF, slightly soluble in ethyl acetate, acetone, ethanol, and 
methanol, and insoluble in water.   
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Figure 2.8 FTIR spectra of polymers with acetylcholine motifs display the presence 
of acetate ester C-O bonds at 1244 cm-1 (arrow).  As expected, this absorption is 
absent in PSA0L100. 
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Table 2.7. Glass transition temperatures and molecular weights of polymers.  
*Polymer batch used in neurite sprouting studies. §Determination of molecular weight by 
universal calibration. 
Molecular Weight Polymer 
Mn Mw 
Tg (ºC) 
13,701 14,324* 3.6 PSA0L100 
6,796 7,981 n/a 
PSA20L80 4,574 7,315 n/a 
PSA40L60 21,303 22,371* 0.3 
6,744 7,966* -6.1 
7,803 10,307 n/a 
18,049 22,272§ n/a 
PSA70L30 
24,517 36,411§ n/a 
4,774 5,141* -24.4 PSA100L0 
5,429 5,770 n/a 
 
2.5 Discussion, conclusions, and future studies in synthesizing polymers 
The abilities to increase the yield of diglycidyl sebacate, optimize the solvent 
amount for the polymerization, and control the molecular weight of the polymers are 
important objectives that can significantly affect the availability of such polymers for 
nerve tissue engineering applications.   
 One way of potentially increasing the yield of diglycidyl sebacate is to utilize an 
alternative synthesis scheme that does not depend on m-chloroperoxybenzoic acid 
(mCPBA).  In the synthesis of diglycidyl sebacate, the use of mCPBA significantly 
increases time and labor, while also causing the isolated yield to be susceptible to the 
purity of the oxidizer.  When sufficient amount of mCPBA is used to oxidize the diallyl 
sebacate, synthesis yield of diglycidyl sebacate is >90% according to NMR of the crude 
product.  The mCPBA, however, must be crystallized overnight and eliminated through 
multiple filtrations using an ionic resin column, adding 13-17 hours of time to obtain 
diglycidyl sebacate.  The mCPBA comes as a mixture of peroxy acid and the reduced 
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benzoic acid.  Because the molar amount of mCPBA required to oxidize diallyl sebacate 
to diglycidyl sebacate is fixed, a lower purity mCPBA requires greater addition of the 
mCPBA-benzoic acid mixture.  This tends to negatively affect isolated yield, since 
diglycidyl sebacate appears to be lost or degraded in the presence of more benzoic acid. 
Optimizing the solvent amount for the polymerizations may lead to increased 
polymer yield and higher molecular weights while preserving the presentation of the 
acetylcholine motif.  Minimizing the use of DMF may lessen the loss of polymer that 
occurs during post-synthesis purification.  Because DMF is toxic to cells, it must be 
thoroughly eliminated from the polymer before in vitro or in vivo use with cells.  Its high 
boiling point (153 ºC) requires the application of high vacuum, heating, induction of 
azeotropes using alternate organic solvents, and washes with water or ether.  The greater 
DMF to eliminate, the more of the polymer is lost due to degradation or increased 
washing steps needed to remove it.  Although the polymerization does proceed in the 
absence of DMF and leads to polymers of increased molecular weight, the resultant 
polymers may also be cross-linked.  This can affect the presentation of the acetylcholine 
motif and cell responses to the material. 
 Polymers of a range of molecular weights may be isolated by controlling the 
duration of the polymerization and utilizing fractional solubilities in organic solvents.  
Characterizing the effect of reaction time on changes in molecular weights may enable 
polymers within a molecular weight range to be isolated.  The longer the reaction time, 
the larger the polymers are expected to become.  However, there may be a bi-phasic 
response of molecular weight with time, since degradation with longer reaction time is 
also possible.  To circumvent this problem, polymers of particular molecular weight 
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ranges may be isolated by fractional solubilities within different organic solvents.  Lower 
molecular weight oligomers may be more soluble low molecular weight alcohols or ethyl 
acetate, while higher molecular weight polymers are likely to precipitate out of such 
solvents.  
In our study, we incorporated leucine ethyl ester into the polymer in order to 
control the concentration of acetylcholine motifs within the polymer.  The concentration 
of leucine ethyl ester, though it has no known effects on neurite sprouting, may mediate 
neurite sprouting.  Instead of leucine ethyl ester, other amino acids with no known effects 
on sprouting, such as isoleucine, alanine, or asparagine, could be used to vary the amount 
of acetylcholine motifs in the polymer.  Instead of acetylcholine motifs, a different 
neurotransmitter motif could be tested.  Another neurotransmitter, such as glutamate or 
glycine, may be incorporated into the polymer to determine whether each provides an 
additional effect that is useful for nerve tissue engineering.  Glutamate would be a 
candidate neurotransmitter for incorporation into the polymer, since its application as a 
soluble gradient induces growth cone turning231.  It would be interesting to determine the 
effect of incorporating glycine into a polymer; unlike acetylcholine, glycine is an 
inhibitory neurotransmitter that attenuates the propagation of the action potential.  The 
neuron’s excitability may play a role in neurite sprouting or other regeneration-related 
responses, such as up-regulation of growth factor receptors or actin polymerization.  
Since cell excitability is affected by neurotransmitter type, polymers based on excitatory 
or inhibitory neurotransmitters may also differentially affect excitability. 
The modular design of synthesizing the acetylcholine-based polymers permits the 
investigation of 1) interactive effects between two or more types of neurotransmitter 
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motifs, and 2) effect of the physicochemical properties of the polymer backbone.  The 
presence of both serotonin and acetylcholine involves interactive effects that mediate 
neurite sprouting218.  Similarly, one can examine the effect of different combinations of 
two or more neurotransmitter motifs in polymers.  Combinations of two or more 
neurotransmitters may be created to determine whether interactive effects exist between 
them that synergistically enhance neurite growth.  In addition to the presence of different 
types and amounts of neurotransmitter motif, another factor that may affect neurite 
sprouting is the polymer backbone.  In this study, we utilized a sebacate backbone to 
permit flexible presentation of the acetylcholine motif.  The backbone can be varied so 
that the polymer is more hydrophilic or hydrophobic, possesses mechanical properties 
closer to the native nerve, or permits cross-linking which can affect the time scale of 
polymer degradation.  Using the same type and amount of neurotransmitter motif, 
polymers based on different linkers can be synthesized to assess how the 
physicochemical properties of the backbone affect neurite sprouting.
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            Chapter 3. APPLICATION OF ACETYLCHOLINE-BASED POLYMERS 
IN NERVE TISSUE ENGINEERING 
 
3.1 Examining the role of Acetylcholine-based materials 
Acetylcholine-based materials may be useful in nerve tissue engineering, as 
acetylcholine influences neurite sprouting, synapse formation, and growth cone turning, 
among other neural cell activities (see Chapter 2, Sections 2.1 and 2.2).  To explore the 
potential of acetylcholine-based materials, we set out to modulate neuronal responses by 
controlling the composition of acetylcholine motifs in a series of polymers.  We 
synthesized and characterized polymers containing different concentrations of 
acetylcholine-like motifs (Chapter 2).   
The interactions between these polymers and neurons are characterized using rat 
dorsal root ganglia (DRG) explants.  DRG relay peripheral stimuli to spinal nerves232 and 
can respond to acetylcholine via multiple cholinergic receptors that are expressed during 
embryonic and postnatal development216,233,234.  Undissociated DRG explants are used 
since this model maintains the three-dimensional relationship between the neurons and 
associated cells within the DRG, providing a more similar environment found in nerve 
regeneration.  We hypothesize that acetylcholine motifs incorporated in a polymer 
modulate neurite sprouting from dorsal root ganglia.  We screened the potential 
application of these materials in nerve tissue engineering using the following criteria: 1) 
neurite sprouting, 2) neurite length, and 3) distribution of the neurite lengths. 
 
 
 
79 
3.2 Materials and methods for in vitro evaluation of acetylcholine-based materials 
3.2.1 Preparation of Surfaces for DRG Culture.  Glass coverslips were washed 
overnight in 1% Alconox detergent, rinsed with deionized water and ethanol, and dried.  
They were coated with 20 μl of the corresponding polymer solution (4.62 mg/ml) in 
DMF and dried overnight at 600 mTorr.  The coated coverslips were then placed in non-
tissue culture treated 24-well plates that were transferred to a vacuum oven at 60°C to 
remove any remaining DMF and to create an even coating.  On the day of DRG isolation, 
each polymer-coated coverslip was sterilized by UV exposure for 30 minutes, and then 
soaked in 1ml of phosphate buffered saline on an orbital shaker (20 rpm) for 30 min (6x).  
A twenty-four well plate was coated with 150 μl of laminin (66.7 μg/ml) (BD 
Biosciences, San Jose, CA) in molecular grade water and placed on an orbital shaker (20 
rpm) overnight prior to seeding. 
 
3.2.2 Dorsal Root Ganglia Culture and Analysis.  DRG from spinal levels L4-L6 of 
postnatal day-3 Sprague Dawley rats were dissected and collected in Hanks’ balanced salt 
solution (Mediatech, Inc., Herndon, VA).  The ganglia were washed with Hanks’ 
balanced salt solution twice and seeded in neurobasal medium supplemented with B-27 
(2%; Invitrogen, Carlsbad, CA), 2 mM L-glutamine, 20 μg/ml gentamycin, and 50 ng/ml 
nerve growth factor onto a pre-coated 24-well plate at one ganglion per well.  Glial 
proliferation was inhibited with 5-fluorodeoxyuridine (7.5 μg/ml) and uridine (17.5 
μg/ml) (MP Biomedicals, Solon, OH).  Half of the medium was first changed at day 3, 
and every third day after.  To test the effect of soluble acetylcholine on the neurite length 
of DRG grown on laminin and PSA0L100, a stock solution of acetylcholine chloride (MP 
80 
Biomedicals, Solon, OH) was added to the media to maintain a final concentration of 1 
mM.  For the antagonist studies, stock solutions of atropine (MP Biomedicals, Solon, 
OH) and mecamylamine (USP, Rockville, MD) in neurobasal medium were first made, 
then diluted to create a final concentration of 100 M.  The culture was maintained in a 
humid 5% CO2 incubator at 37°C.  DRG were fixed and stained for synaptophysin using 
rat anti-synaptophysin monoclonal antibody (Biomeda Corp., Foster City, CA) and Alexa 
Fluor 594 fluorescently labeled goat anti-mouse IgG antibody (Invitrogen, Carlsbad, 
CA). 
The area of neurite outgrowth was photographed using an inverted phase contrast 
microscope [Nikon TE-2000U microscope (Melville, NY) equipped with a 4 MP 
Diagnostics Spot Flex digital camera (Sterling Heights, MI)].  Adobe Photoshop CS2 
(San Jose, CA) was used to merge the photos and outline the neurites using the ‘find 
edge’ function.  DRG exhibiting one or more neurites were considered to be sprouting.  
DRG with no neurites were considered ‘not sprouting’.  Day 4 neurite length 
measurements were performed on each ‘sprouting’ ganglion whose growth was 
unimpeded by the well’s perimeter.  Neurite length was measured by tracing the path of a 
neurite from the boundary of the dorsal root ganglion to the tip of the neurite.  Upon 
reaching a branching point, length was traced along the path yielding the greater length.  
No neurites with the same branching points were measured.  The 10 longest neurites of 
each ganglion were measured with ImageJ (NIH, Bethesda, MD).   
 
3.2.3 Statistical Analysis.  Binary logistic regression was used to assess and determine 
the nature of the relationship between acetylcholine-motif concentration and probability 
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of sprouting.  Because the neurite sprouting response can be considered to be a binary 
response, the logit transformation was used: 
    2210 %*%*1ln iii
i AchbAchbb 




 ,  Equation 1 
where i  is the probability of sprouting and (Ach%)i is the concentration of 
acetylcholine-motifs of the polymer.  Maximum likelihood estimates of the coefficients 
b0, b1, and b2 were found using the statistical software program Minitab 15 (State 
College, PA).  Coefficients were considered to be statistically significant at p-values less 
than 0.05.  
  Error bars for adherent and sprouting percentages were calculated as the 95% 
confidence interval for the proportion being estimated using the normal approximation to 
the binomial distribution.  Chi-squared homogeneity testing was used to evaluate 
statistical significance of the difference in substrates’ ability to promote neurite sprouting.  
Analysis of variance was used to determine whether differences in neurite sprouting area 
were statistically significant. 
 
3.3 In vitro responses of DRG to acetylcholine-based polymers 
3.3.1 Neurite sprouting.  To investigate how ALFs modulate neurite sprouting, the 
polymers were coated onto glass coverslips.  Neurite growth was monitored daily.  
Measurement of neurite length was reliable up to approximately 4-6 days because 
extensive networks of neurites formed beyond 6 days.  The data on neurite sprouting was 
obtained on day 4.  All polymer-coated coverslips were sterilized with UV light.  ATR-
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FTIR spectra of each polymer before and after UV exposure showed no change, 
indicating that the integrity of the polymer was preserved.   
DRG cultured on the polymer-coated coverslips exhibited growth of one or more 
neurites, or no neurites at all (Figure 3.1).  ‘Sprouting’ DRG exhibited one or more 
neurites, while those with no neurites were considered to be ‘non-sprouting.’  The neurite 
sprouting area response varied considerably on a polymer of a given acetylcholine motif 
concentration (Figure 3.2).  Measuring the neurite sprouting area of DRG with one or 
more neurites revealed that there was not a statistically significant difference in neurite 
area when DRG were cultured on different polymer surfaces (p = 0.166).  There was no 
difference in neurite sprouting area when DRG were cultured on laminin and the polymer 
surfaces (p = 0.118).  Arbitrary segmentation of the data is averted by utilizing a general 
definition to characterize DRG responses to the polymers and using the classification 
‘sprouting’ vs. ‘non-sprouting’ as an indicator of growth. 
 
Figure 3.1.  DRG were considered to be either non-sprouting (a) or 
sprouting (b). 
ba 
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Figure 3.2.  Neurite sprouting area on polymers containing various acetylcholine 
motif concentrations.  Observations were made from 8, 16, 12, 5 DRG cultured on 
PSA0L100, PSA40L60, PSA70L30, and PSA100L0, respectively. 
 
Logistic regression revealed that the sprouting ability of DRG was influenced by 
the concentration of acetylcholine motifs of the polymer.  This analysis considers each 
DRG as an independent trial that exhibits either a sprouting or non-sprouting response 
(Figure 3.1).  Because the sprouting response can be considered to be a binary response, 
the logit transformation was used: 
    2210 %*%*1ln iii
i AchbAchbb 



 
    Equation 1 
where i  is the probability of sprouting, (Ach%)i is the concentration of 
acetylcholine-motifs of the polymer, i corresponds to the ith DRG, and b0, b1, and b2 are 
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coefficients determined by maximum likelihood estimation.  After running a binary 
logistic regression package on the data, the values corresponding to the acetylcholine 
motif terms, b1, and b2, were determined to be statistically different from zero at the p-
values listed (Table 3.1).  The model is significant, and therefore, concludes that the 
probability of neurite sprouting depends on the concentration of acetylcholine motifs.  
Substituting the coefficient values into Equation 1 gives the fitted response function: 
    2210 %*%*ˆ1
ˆ
ln ii
i
i AchbAchbb 




   Equation 2 
where iˆ  is the average sprouting response corresponding to a concentration of 
acetylcholine motif.  Goodness of fit tests were performed using the statistical package, 
and included Pearson, Deviance, and Hosmer-Lemeshow tests.  All tests indicated that 
the data was modeled adequately.  
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Table 3.1.  Estimates of the coefficients for logistic regression. 
Parameter Value p-value (non-zero parameter) 
b0 -0.695662 0.111 
b1 0.0540668 0.006 
b2 -0.0006091 0.001 
 
DRG sprouting on polymers containing-acetylcholine motifs were compared with 
responses observed on laminin and with the addition of soluble acetylcholine.  Within the 
family of synthesized polymers, PSA70L30 was the most efficient at promoting neurite 
sprouting, with 59.1 ± 20.5% of DRG having sprouted at least 20 neurites, which is 
comparable to 60.0 ± 21.5% on laminin (Figure 3.3).  PSA40L60 also prompted 
considerable growth with 57.1 ± 18.3% of DRG sprouting neurites.  PSA100L0 and 
PSA0L100 both showed markedly decreased sprouting compared to PSA70L30 and 
PSA40L60.  Sprouting on PSA100L0 and PSA0L100 may have been induced by positive 
charges, due to the amines on the polymer backbone, that are known to encourage neurite 
extension.180,235  Alternatively, the DRG that sprouted may have been the most robust 
DRG that were capable of sprouting irrespective of the surface condition. 
To assess whether solution-phase acetylcholine affects neurite sprouting, DRG 
were cultured on PSA0L100 and laminin in the presence of 1 mM of the neurotransmitter.  
The addition of acetylcholine increased the fraction of DRG exhibiting neurite sprouting 
on PSA0L100 from 34.8 ± 19.5% to 38.1 ± 20.8% (Figure 3.3).  This difference, however, 
was not statistically significant.  Soluble acetylcholine may mediate its effects differently 
from the acetylcholine motif, which is covalently bound to the polymer until hydrolysis.  
Binding of acetylcholine to the receptor can cause internalization of the 
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neurotransmitter236,237 whereas it is yet unknown whether the acetylcholine motif 
interacts with the acetylcholine receptor and is processed in the same manner.  The 
addition of solution-phase acetylcholine did not significantly alter neurite sprouting on 
laminin.  Laminin’s ability to promote outgrowth is well-established and involves 
specific growth-promoting domains,118,120 integrin-binding domain,121 and a heparin-
binding domain.114  Addition of 1 mM acetylcholine may not have significantly impacted 
neurite growth on laminin because of the existence of many other neurite sprouting cues.  
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Figure 3.3. Effect of polymer composition and soluble acetylcholine on DRG 
sprouting.  DRG were cultured on polymers containing acetylcholine motifs or laminin, 
and with soluble acetylcholine added to a final concentration of 1 mM (+ Ach).  Error 
bars indicate 95% confidence interval.  DRG sprouting responses on polymers that do not 
have overlapping 95% confidence intervals are statistically different, * p<0.05.  N: total 
number of DRG cultured. 
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3.3.2 Neurite length.  For nerves to regenerate successfully, a biomaterial should 
support the extension of the sprouted neurites.  The activation of acetylcholine receptors 
by the addition of acetylcholine agonists significantly increased neurite outgrowth and 
length217.  Acetylcholine motifs within a biomaterial could also affect neurite extension.  
To assess extension of neurites on the polymers, we measured the 10 longest neurites per 
ganglion, pooled the data from the sprouting DRG on each substrate, and compared the 
distribution of neurite lengths.    
Long neurites grew on all surfaces and the acetylcholine motif content affected 
the distribution of the longest neurites.  DRG on both PSA0L100 and PSA70L30 exhibited 
long neurites at 2.93 mm and 2.77 mm, respectively (Table 3.2).  However, more DRG 
adhered to and sprouted on PSA70L30 than PSA0L100 (Figure 3.3).  Additionally, a greater 
fraction of neurites grew longer than 2.0 mm on PSA70L30 than the other polymers (Table 
3.3).  It is possible that the neurite lengths were affected by the number of neurons within 
a DRG, and the existence of this potential measurement artifact was checked.  Neurite 
density measurements, normalized to the area of the DRG, revealed neurite densities 
were similar among DRG considered to be ‘sprouting’.  Furthermore, within the same 
group of DRG, the neurite area was not statistically different.  Therefore, the different 
neurite length distributions were not likely due to differences in the sizes of the DRG or 
population distribution of the neurites. 
The growth rate of the longest neurite, when averaged over four days, on 
PSA70L30 was 692 μm/day.  The rigor of this growth rate is maintained up to 6 days, and 
decreased slightly to 601 μm/day by day 8.  This appears to be higher than the DRG 
growth rates of 250 μm238 to 370 μm128,239 per day calculated from data reported in the 
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literature.  Nerve growth in vivo is much more complicated than culturing DRG explants; 
in vitro neurite growth rate nonetheless provides a measure of the material’s propensity to 
promote nerve growth.  Adding acetylcholine to the culture medium of DRG on PSA0L100 
and laminin appears to have a positive effect on neurite extension.  The maximum 
observed neurite length of DRG seeded onto laminin increased from 3.49 mm to 4.59 
mm.  On PSA0L100, the addition of acetylcholine nearly doubled the fraction of neurites 
with lengths between 2.0 to 2.5 mm (Table 3.2). 
Table 3.2. Distribution of longest neurite lengths.  DRG were cultured on polymers 
containing acetylcholine motifs or laminin, and with soluble acetylcholine added to a 
final concentration of 1 mM (+ Ach). 
    % neurite with length [mm] 
 
Max neurite 
length [mm] 
> 3.5 
mm 
3.0 - 
3.5 
2.5 - 
3.0 
2.0 - 
2.5 
1.5 - 
2.0 
< 1.5 
mm 
PSA0L100 + Ach 2.61 - - 5 30 33 32 
PSA0L100 2.93 - - 7 17 33 43 
PSA40L60 2.54 - - 1 5 40 54 
PSA70L30 2.77 - - 7 31 36 26 
PSA100L0 2.28 - - - 20 65 15 
Laminin 3.49 - 4 20 34 16 26 
Laminin + Ach 4.59 2 2 19 14 7 56 
 
3.3.3 Neuronal phenotype.  Functional restoration after nerve injury requires synapse 
formation between neurons and their target tissue and, in certain cases, between neurons 
as well.  We examined the presence of synaptic vessicle proteins on all polymers in order 
to evaluate the maintenance of neuronal phenotype.  DRG seeded on PSA70L30 and 
laminin both expressed synaptophysin (Figure 3.4), an established neuronal marker, up 
to 21 days in culture.240  DRG on the remaining polymers also stained positive for 
synaptophysin.  This indicates that neurons grown on ALF-containing polymers can 
retain phenotypic protein expression. 
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3.3.4 Neurite sprouting in the presence of acetylcholine antagonists.  The sebacate 
polymer backbone is designed to permit flexible presentation of the acetylcholine motif, 
which may interact with acetylcholine receptors expressed on DRG233,234.  Acetylcholine 
binds to two types of receptors, nicotinic and muscarinic receptors.  Nicotinic receptors 
are ligand-gated ion channels that upon binding of two acetylcholine molecules, open to 
allow the passage of sodium ions.  The depolarization caused by the influx of sodium 
then leads to the opening of voltage-gated calcium channels, subsequently leading to the 
influx of calcium into the cell241.  Muscarinic receptors are G-protein coupled receptors 
that have two main activities associated with them.  Binding of acetylcholine to 
muscarinic receptors may activate phospholipase C activity or the inhibition of adenylyl 
cyclase activity242.       
To examine interactions between acetylcholine receptors and polymers containing 
acetylcholine-motifs, DRG were cultured in the presence of nicotinic and muscarinic 
antagonists.  One-hundred micro-molar of each antagonist were added separately to DRG 
cultured on polymers and on laminin.  Addition of nicotinic and muscarinic receptor 
antagonists, mecamylamine or atropine, respectively, to polymers with acetylcholine 
motifs decreased neurite sprouting in a statistically significant manner (Figure 3.5).  
Addition of the antagonists to DRG culture on laminin, in the same concentration, did not 
significantly affect neurite sprouting.  These results suggest that the acetylcholine 
receptor mediates neurite sprouting on polymers containing acetylcholine-motifs.  
Activation of acetylcholine receptors has been shown to enhance neurite outgrowth in 
previous studies217,243, and application of antagonists in the presence of acetylcholine 
agonists similarly led to attenuation of neurite sprouting and extension217,243.   
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Figure 3.4.  DRG were stained for the synaptic vesicle protein synaptophysin 
when cultured on polymers containing acetylcholine motif (a) and laminin (b). The 
presence of numerous synaptic vesicles is indicated by punctate red spots along the 
neurites. Day 21, 200 x, scale bar = 200 m. 
a 
b 
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3.4 Discussion, conclusions and future studies in the evaluation of new polymers 
for nerve tissue engineering 
The studies presented here indicate acetylcholine motifs in materials modulate 
neurite sprouting from DRG.  Among the polymers that were tested, polymers of 
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Figure 3.5.  Addition of acetylcholine antagonists significantly decreases DRG 
sprouting on polymers with acetylcholine motifs (a) but not on laminin (b).  
Error bars indicate 95% confidence interval.  DRG sprouting responses on 
polymers that do not have overlapping 95% confidence intervals are statistically 
different, * p<0.05.  N: total number of DRG cultured.   
a 
b 
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intermediate concentrations of acetylcholine motifs were most effective at promoting 
sprouting.  All polymers permitted neurite extension and maintained the neuronal 
phenotype.  Antagonist binding studies suggest that acetylcholine motifs interact with 
receptors to mediate neurite sprouting.  Addition of acetylcholine agonists have similarly 
induced a significant increase in fiber outgrowth in chick DRG, an effect which was also 
abolished in the presence of receptor antagonists217.  These studies suggest the potential 
use of acetylcholine-based polymers in nerve tissue engineering.  Future studies for 
assessing the their applicability involve understanding cell-material interactions between 
neurons and the polymers and examining how acetylcholine motifs may play a role in 
other relevant responses involved in nerve regeneration.  
The antagonist binding study suggests the polymer interacts with the acetylcholine 
receptor; further studies are required to establish this interaction.  Downstream events 
following acetylcholine receptor activation may be assessed, such as the activation of 
phospholipase C, inhibition of adenylyl cyclase, changes in intracellular calcium levels, 
or differences in electrical activity of neurons.  These studies will compare whether 
acetylcholine motifs can induce changes in cell activities that are similar to acetylcholine 
(or its agonists), and whether these activities can be abolished by the presence of 
competing antagonists.     
The acetylcholine motif may interact with muscarinic or nicotinic acetylcholine 
receptors.  Phospholipase C activity, which is associated with the Gq activity of a subset 
of muscarinic receptors242, can be monitored by the amount of inositol phosphate 
produced as a function of the concentration of acetylcholine motifs.  Another subset of 
muscarinic receptors may also be involved – those having a Gi activity that inhibits 
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adenylyl cyclase activity242 – and can be examined similarly by monitoring changes in 
cAMP levels when the concentration of acetylcholine motifs is increased.  Controls for 
each study would involve assessing the baseline level of phospholipase C in the cells, the 
baseline level of cAMP in unstimulated neurons, cAMP levels when its production is 
induced, and the effect of adding increasing concentration of an acetylcholine agonist, 
such as carbachol, on phospholipase C and adenylyl cyclase activities.   
Upon the binding of acetylcholine to neuronal, nicotinic acetylcholine receptors, 
the ion channels are permeated by extracellular calcium241.  Influx of extracellular 
calcium have been shown to activate actin transcription in neuron-like PC12 cells220, 
while the resulting depolarization from the influx of calcium stimulates lamellipodia 
formation and axonal branching in cerebral cortex neurons167.  Calcium transients also 
play a role in inducing axon branching in cortical neurons by targeting the 
calcium/calmodulin-dependent protein kinase II164.  The acetylcholine motifs may 
interact with acetylcholine receptors through similar mechanisms involving changes in 
calcium levels.   
Cell excitability, measured by intracellular calcium imaging or 
electrophysiological recordings, may be used to assess the involvement of acetylcholine 
receptors.  The intracellular calcium levels of neurons cultured on acetylcholine-based 
polymers can be monitored with fluorescent probes that are sensitive to free calcium in 
the cell, and compared with cells cultured on laminin or PSA0L100.  If acetylcholine 
motifs activate nicotinic receptors on neurons, there is likely to be a greater magnitude of 
changes in the levels and frequency of calcium influxes on cells cultured on the polymers 
with acetylcholine motifs compared to laminin or PSA0L100.  Whole-cell patch clamping 
94 
can also be used to evaluate whether neurons’ electrical activity are affected by the 
substrate on which they are cultured.  Extracellular patch clamp is useful in assessing 
whether an ionic current can be induced when cells expressing acetylcholine receptors are 
exposed to the acetylcholine motif.  Additionally, the increasing concentration of the 
acetylcholine motif may be applied to determine whether changes in cell excitability are 
proportional to the concentration. 
Hydrolysis of the polymer’s ester bonds is likely to result in an amine-containing 
degradation product (Figure 3.6), referred to as the ‘tentative active component.’  
Isolating and testing it on neurons could further elucidate how acetylcholine-based 
polymers affect neurite sprouting.  It is unknown whether acetylcholine motifs bound to 
the sebacate backbone, those free in solution as the tentative active component, or both, 
can activate acetylcholine receptors.  A preliminary study would be to investigate if 
acetylcholine motifs as oligomers or as the tentative active component elicit cell 
responses (those mentioned above) associated with acetylcholine receptor activation.  
Different magnitudes of cell responses may be observed that depend on the presentation 
of the motif as an oligomer or the tentative active component.  To evaluate which is more 
effective at activating the acetylcholine receptor, cell responses as a function of time can 
be compared when equivalent concentrations of acetylcholine, oligomer, or tentative 
active component are added.  Determining how the presentation of acetylcholine motifs 
affects receptor activation, and subsequent signaling pathways, could be useful for re-
designing the polymer to optimize neurite growth.   
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The acetylcholine-based polymers may be used to study effects on other responses 
that are relevant to nerve tissue engineering – such as neurite guidance and 
synaptogenesis.  The role of acetylcholine in growth cone guidance has been shown, as 
growth cones secrete the neurotransmitter221 and turn toward acetylcholine gradients10.  
To test whether acetylcholine-based polymers can induce growth cone turning, polymers 
containing the motif can be selectively patterned onto a growth permissive substrate.  
Observations of the neurite morphology can be made to assess whether neurite growth 
coincides with regions containing the acetylcholine-based polymer.  It would also be of 
interest to see whether acetylcholine-based polymers can promote and guide neurite 
growth in the presence of myelin or myelin-associated inhibitors, since in vivo nerve 
regeneration in the central nervous system is likely to occur in their presence.  The 
soluble form of the polymer, either as a tentative active component (Figure 3.6) or a low 
molecular weight oligomer, may also affect growth cone turning that was similarly seen 
with gradients of acetylcholine.  Identifying whether the growth cone can be induced to 
 
Figure 3.6.  Tentative active component of acetylcholine-based polymers resulting 
from the hydrolysis of ester bonds on the polymer backbone. 
96 
turn towards gradients of the soluble polymer may provide an alternative strategy to 
guide neurite extension using soluble, neurotransmitter-based motifs.        
The spontaneous secretion of acetylcholine in developing neurons221 implicates 
acetylcholine’s role in synapse formation.  The potential role of acetylcholine motifs in 
synaptogenesis may be investigated by quantifying the number of synapses formed on 
acetylcholine-based polymers vs. PSA0L100 (or other substrate lacking acetylcholine 
motifs) using immunohistochemistry for pre-synaptic and post-synaptic markers.  More 
importantly, the formation of functional synapses should also be assessed by eliciting an 
action potential and determining the efficiency of its propagation.  In vitro evaluation of 
functional synapse formation may be performed by applying a current to one neuron, then 
measuring the speed and the magnitude of the current’s propagation through other 
neurons interacting with it using voltage clamping.  Similarly, an in vivo evaluation of 
functional synapse formation may be performed by quantifying the speed of propagating 
an action potential along a nerve regenerated using the acetylcholine-based material vs. a 
control polymer lacking the motif, such as PLGA or PSA0L100.   
Acetylcholine-motifs may also play a role in cell differentiation and apoptosis.  
Activation of acetylcholine receptors have been shown to induce actin transcription220 
and neuro-filament expression217, and protect cells from apoptosis induced by DNA 
damage, oxidative stress, and mitochondrial impairment223.  Acetylcholine-based 
polymers might also affect these processes, and may be useful in differentiating stem 
cells or preventing extensive cell death that usually results from nerve injuries.  
Differentiation of stem cells on the acetylcholine-based polymers can be assessed by 
monitoring the expression of the neuronal proteins neurofilament, tau, or 
97 
synaptophysin240, and comparing those levels to cells cultured on on PSA0L100.  
Evaluating the potential of acetylcholine-based polymers in preventing apoptosis may be 
achieved by assessing their effect on promoting survival in response to an insult through 
cell number of differences in the expression of apoptosis-related proteins (such as 
caspase, bcl-2, bax).  
Future studies discussed so far involve examining the role of acetylcholine motifs 
on neurons; glial cells expressing acetylcholine receptors may also respond to the 
neurotransmitter motif.  Muscarinic acetylcholine receptors on are involved in cell cycle 
progression244, proliferation245,246, and progenitor cell survival247 of Schwann cells248, 
astrocytes245, and oligodendrocytes249.  Activation of nicotinic acetylcholine receptors on 
astrocytes also significantly increases intracellular calcium ions250.  Furthermore, glial 
cells may indirectly modulate neuronal responses by secreting acetylcholine-binding 
protein251.     
Acetylcholine-based polymers may directly affect glial cell processes and their 
functional abilities in expediting nerve regeneration after injury.  Glial cells can be 
cultured onto polymers with acetylcholine motifs to assess its effects on proliferation or 
on cell survival in the presence of apoptosis-inducing factors.  Cell excitability, caused by 
the influx of ions, may play a role in modulating astrocyte reactivity in vivo.  Because 
such proteins are upregulated in reactive astrocytes, GFAP and ezrin immunoreactivity in 
spinal cord lesions treated with scaffolds containing the acetylcholine motif polymer may 
elucidate whether such polymers can affect astrocyte reactivity252.  Potentially 
modulating astrocyte activity through interactions with the acetylcholine motif could be 
useful for myelination, as astrocytes can modulate the myelinating ability of 
98 
oligodendrocytes36.  Direct interactions between the acetylcholine motifs and 
oligodendrocytes might also influence whether acetylcholine motifs affect growth factor 
production, and can be assessed by assaying neurotrophic content of conditioned media 
isolated from cells grown on the polymer.         
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Chapter 4.   SCAFFOLD FABRICATION TECHNIQUE OF  
NERVE GUIDANCE CHANNELS 
4.1 Fabrication of nerve guidance scaffolds 
Nerve guidance channels may be used to enhance regeneration after injury by 
providing a physical substrate, delivering growth factors, facilitating the arrangement of 
cells, or a combination of these functions.  The material, growth factors, and cells 
included in the scaffolds influence neuronal and the overall regenerative responses 
(Sections 1.4.1 to 1.4.4).  Additionally, the topographical cues presented in the scaffold’s 
dimensions253, microtopography254, and porosity255-258 affect in vivo responses as well, 
although the exact relationship between scaffold properties and responses are not fully 
determined.  This is due in part to confounding variables wherein the effect of the 
topographical cue was not completely isolated – for example, cases in which two 
different materials were used to investigate a topographical effect.  Controlling the 
scaffold properties within the same material may enable an improved understanding of 
how such properties affect neurite extension, myelination, functional synapse formation, 
and functional recovery.   
Scaffolds of aligned fibers or having longitudinally oriented channels are being 
investigated for their ability to direct growth.  Their increased surface area and uni-
directional nature are designed to promote cell adhesion and guide regeneration toward 
the target of nerve re-innervation.  Evaluation of aligned fibers in peripheral nerve 
regeneration models indicate an enhancement of myelination, axonal area28,31,259, and 
muscle innervation259 compared to un-aligned fibers.  Electrospinning has most often 
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been used to produce these aligned fibers, though solvent precipitation technique has also 
been employed260.   
An alternative approach for inducing topographical guidance involves scaffolds 
with multiple channels.  These have been designed to mimic the endoneurial structure 
found in peripheral nerves.  Scaffolds containing multiple, longitudinally oriented 
channels have been fabricated using laser ablation261, induced phase separation23,60,200,262, 
and fiber templating24,25,201,263-266.  While these methods are capable of producing 
channels, there is difficulty in controlling processing parameters to achieve the desired 
scaffold properties.  The laser ablation technique was used to create channel impressions 
onto a porous polymer of 100 m depth261; scaffolds for peripheral nerve regeneration 
would likely be much longer than such depths.  The induced phase separation method 
does not ensure that channels go through the entire length of the scaffold.  Fiber 
templating has been successful at creating scaffolds with longitudinal channels.  This 
method, however, provides little control over pore sizes and distribution, which are 
important parameters influencing the diffusion of nutrients or in the migration of cells 
into the scaffold. 
We present a method for fabricating macroporous scaffolds with longitudinal 
channels using a combination of salt leaching and fiber templating.  We tested the effects 
of the size of the salt particles and the number of fibers on average pore size and channel 
volume, respectively.  Scaffolds were fabricated from poly(glycerol sebacate), since this 
polymer has comparable mechanical properties to the peripheral nerve and is 
biocompatible in nerve regeneration applications267.  The fabrication method presented 
here may also be used to control porosity and channel dimensions.    
101 
4.2 Materials and methods for creating and characterizing scaffolds 
4.2.1 Preparation of scaffolds.  Poly(glycerol sebacate) was synthesized according to 
previously published method268.  Salt particles were ground using a mechanical grinder 
and sifted according to particle size using 25-32 m and 25 m sieves (ASTM Nos. 450 
and 500, respectively) then stored in a dessicator to prevent aggregation.  Teflon fibers 
were soaked in a saturated salt solution, frozen, and then lyophilized in order to coat the 
fibers with a layer of salt.  Teflon molds, each consisting of half a cylinder cut along its 
longitudinal axis (Figure 4.1), were filled with alternating layers of salt and fibers.  250 
mg of salt was used per mold, with 25 or 50 salt-coated Teflon fibers.  The salt and fibers 
were gently packed into the mold using the flat edge of a metal spatula.  Molds with salt 
and fibers were placed in a 37°C, humidified chamber for 1 or 2 hours, and then into a 
37°C vacuum chamber overnight.  250 l of 0.2 g/ml of poly(glycerol sebacate) in 
tetrahydrofuran was added to each mold, and the solvent was allowed to evaporate in a 
chemical hood for at least 30 minutes.  The molds were transferred to a 150°C vacuum 
oven and the polymer was cured for 48 hours.  Salt leaching was performed by 
immersing 6-8 scaffolds in 2L of agitated, de-ionized water, which was changed every 12 
hours for 48 hours.  Teflon fibers were gently extracted from the wet scaffold by holding 
it between the index finger and thumb and pulling out fibers one at a time.  
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4.2.2 Topographical analysis by cryo-sectioning, SEM, and micro-CT.  Cross 
sectional micro-structure was analyzed on randomly-selected scaffold segments using a 
scanning electron microscope (SEM).  Scaffold samples were attached to aluminum 
mounts with carbon tape, sputter-coated with gold using a Polaron SC7640 High 
Resolution Sputter Coater (Quorum Technologies, Newhaven, United Kingdom), and 
observed with a Leo 1550 SEM (20 kV, 3-5 nm spot size).  The presence of channels in 
the scaffold was examined by embedding the scaffold in Tissue-Tek Optimal Cutting 
Temperature (OCT) Compound (Sakara Finetek U.S.A., Torrance, CA) and 
cryosectioning a 10 mm section of the scaffold into 100 m-thick sections.  Sections 
were imaged by bright field microscopy on an inverted microscope [Nikon TE-2000U 
microscope (Melville, NY) equipped with a 4 MP Diagnostics Spot Flex digital camera 
(Sterling Heights, MI)].  Micro-CT analysis was performed on a Scanco Medical CT 40 
micro-computed tomography scanner (Southeastern, PA), and used to determine the 
porosity, average pore size, and pore size distributions of the scaffolds with a voxel size 
of 6 m.   
 
 
Figure 4.1.  Schematic of Teflon mold used to create scaffolds.  Top view (a) and 
side view (b). 
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4.2.3 Statistical Analysis.  Analysis of variance was applied to determine whether 
differences in average pore size and channel volume were significant (p < 0.05). 
    
4.3 Results of Topographical Analysis 
4.3.1 Image Analyses.  Imaging by micro-CT revealed that longitudinally oriented 
fibers were embedded throughout the length of the scaffold (Figure 4.2).  Analyses by 
SEM and cryo-sectioning were performed to assess the presence of micro-pores and 
longitudinal channels once the fibers were removed.  Cross-sectional images of the 
scaffold show that micro-pores were present throughout it (Figure 4.3) and that 
extraction of the fibers led to open channels (Figure 4.4).  Comparing an area on one 
picture with the same area on a subsequent section shows that channels remain open, with 
the possibility of separation or merging of channels. 
Micro-CT, SEM, and cryosections of the scaffold indicate that micro-porous 
scaffolds with longitudinally oriented channels were formed with the salt fusion and fiber 
templating method.  Fibers maintained their alignment to the axis of the scaffold mold 
through salt packing and salt fusion steps.  Teflon fibers were successfully extracted from 
scaffolds of 10 mm length.  There was no observed breakage of fibers during extraction, 
as determined by examining each of their lengths and comparing it with the length of the 
scaffold.  The salt leaching step allowed micropores to form within scaffolds, as revealed 
by SEM analysis.  Holes smaller than the salt particle sizes employed were also observed, 
and can be attributed to the evaporation of glycerol formed during the polymer curing 
process. 
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Open channels remained after Teflon fibers were extracted.  Because the fibers 
were not exactly parallel to one another during the fabrication process, one channel could 
merge with another.  This may affect regeneration in vivo by causing neuronal processes 
to cross paths, and may lead to inexact reconnection of the nerve bundles at the distal and 
proximal ends of the nerve gap.  It is also possible that merging nerve bundles may lead 
to paracrine stimulation that could further enhance neurite elongation.  The effects of 
crossed channels on the regenerative response are still unknown.  Further improvements 
on ensuring channel separation could be used to fabricate scaffolds with completely 
separated channels, and gauge differences in biological responses in the future.  
Meanwhile, topographical cues’ influence on nerve regeneration through scaffold 
dimensions can be investigated. 
 
 
Figure 4.2.  Micro-CT analysis of PGS scaffold containing Teflon fibers.   
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b
c d
Figure 4.4.  Longitudinally-oriented channels remain after the extraction of 
fibers.  Images were obtained by cryosectioning scaffolds into 100 m-thick slices.  
Consecutive sections (a-d) along the length of the scaffold. Scale bar = 1 mm.   
a 
Figure 4.3.  SEM image of scaffold cross-section showing its porous nature.  A salt 
template consisting of 32 – 45 m particles were fused and 100 fibers were embedded 
for the production this particular scaffold.
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4.3.2 Analysis of Scaffold dimensions by micro-CT.  We attempted to control the 
channel volume, pore size, and pore distribution by varying the number of fibers, salt 
particle sizes, and salt fusion time used during the scaffold fabrication.  Micro-CT scans 
were used to determine the volume occupied by fibers, the average pore size, the 
distribution of the pore sizes, and the volume fraction occupied by the polymer scaffold.  
 Volume occupied by the channels is proportional to the number of fibers 
embedded in the scaffold.  Doubling the number of fibers increased the channel volume 
by roughly 2-fold (Figure 4.5).  Twenty five fibers occupied 1.3 % of the total scaffold 
volume, compared with 2.7% occupied by 50 fibers.     
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 In order to control average pore size and pore size distribution, different-sized salt 
particles and fusion times were tested.  Salt particles of two different distributions were 
obtained by sieving – less than 25 m or particles between 25 and 32 m.  After fibers 
Figure 4.5.  Channel volume as a fraction of scaffold volume.  Scaffolds made 
with 50 fibers had approximately twice the channel volume as scaffolds made with 
25 fibers. *p < 0.05.  Error bars = standard deviation.  N = 6 samples per condition.
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and salt were added to a mold, the salt was fused for 1 or 2 hrs.  The salt particle size had 
a statistically significant effect on the average pore size of the scaffolds at fusion times of 
2 hours (Figure 4.6).  The salt particle size did not have an effect on average pore size 
when salt was fused for 1 hour.  Increasing the fusion time from 1 to 2 hours greatly 
decreased the variance of the average pore size in statistically significant manner (Figure 
4.6).  The average pore size depends largely on the salt particle size and while 
distribution of particle sizes can be affected by the salt fusion time.   
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Figure 4.6.  Two hour fusion time enhances differences between average pore 
sizes due to salt particle size.  Longer fusion time decreases variance associated 
with salt particles,*p<0.05   
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4.4 Discussions, conclusions and future studies in the fabrication of microporous 
scaffolds with longitudinally aligned channels 
We have presented a fabrication method for a micro-porous scaffold containing 
longitudinally oriented channels.  We showed that the channel volume, average pore size, 
and distribution of the pore sizes can be controlled through the fiber number, salt particle 
size, and salt fusion time, respectively.  Although it was not examined in this study, there 
are other scaffold dimensions that may be controlled using this fabrication method.  
Porosity is likely to be influenced by the amount of salt added to the mold and the 
number of channels.  Channel diameter is controllable through the fiber diameter.  
Methods that have been previously used to create aligned channels in scaffolds include 
unidirectional freezing199,200 and templating24-26.  Compared to these techniques, the 
scaffold fabrication technique presented here allows additional control over pore size, 
porosity, channel volume and dimensions while enabling the presentation of aligned 
channels.   
Future process improvements involve ensuring channel separation and decreasing 
fabrication time.  Because channels’ merging could cause regenerating nerves to 
intertwine and lead to incorrect reconnection of the nerve ends, a scaffold with separate, 
longitudinal channels may be more ideal.  To improve separation of the fibers, a mold 
with fully open ends could be used (Figure 4.7).  The fully open ends would not confine 
fibers as closely as the current mold and allow them to disperse more evenly.  
Furthermore, salt particles and fibers may be more easily layered into this space, which 
can decrease the fabrication time.  Much of the effort in the current fabrication method is 
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spent ensuring that salt particles are interspersed between fibers, which is more difficult 
when fibers are so closely associated together using the current mold.   
Testing the scaffolds of varying dimensional properties in vivo nerve regeneration 
may give a better understanding on how scaffold properties affect regeneration.  
Observing how the channel volume or diameter affects the rate of axonal extension or 
infiltration of Schwann cells into the scaffold is useful in the design of a nerve guidance 
channel.  The effect of pore size and pore distribution on the ability to different cell types 
to enter the scaffold may also be used to facilitate growth.  For example, the presence of 
reactive astrocytes in a spinal nerve guidance channel would be undesirable, whereas 
successful migration of endothelial cells into a peripheral nerve guidance channel could 
encourage vascularization.  Topographical cues, in the presence of other growth-
promoting stimuli, could also have synergistic effects.  Scaffolds may be combined with 
neurotrophic factors, extracellular matrix cues, neurotransmitter-based materials, or all of 
these, to maximize the regeneration response.  
 
 
Figure 4.7.  Design of molds for nerve guidance scaffolds may be used to 
control spacing of channels within scaffold.  Top view of a) Current mold 
for fabrication  b) Mold with open configuration  
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 Topographical guidance may exert its various influences on cells through cell 
adaption mechanisms or by inducing alterations in protein adsorption269.  Filopodial 
interactions with materials suggest that they play a role in sensing topographical 
surroundings.  Differences in interfacial forces could be interpreted by cells by 
influencing focal adhesion formation and cytoskeleton structure270.  Cells may then adapt 
to local environments by controlling the secretion of extracellular matrix proteins271.  
Another possible mechanism for topographical guidance involves alterations in adsorbed 
proteins, which could result from differential wetting of surfaces, surface energy 
differences, or changes in surface area.  Local concentrations of adsorbed proteins can 
vary according to wetting of surfaces272, potentially through changes in hydrophobicity 
along patterned surfaces273.  Proteins may also preferentially adsorb to topographical 
surfaces with increased surface energy274,275 or higher surface areas14,276.             
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       Chapter 5.   CONCLUSIONS, PERSPECTIVES AND FUTURE STUDIES 
5.1  Conclusions 
The goals of this thesis were to: 1) synthesize polymers with control over the 
polymer backbone and amount of acetylcholine-like motifs; 2) assess the effect of 
acetylcholine motif concentration on neurite sprouting in vitro; and 3) fabricate nerve 
guidance channel that is both microporous and contains longitudinally oriented channels.  
A modular synthesis design enabled materials to be made that possess covalently-bound 
acetylcholine motifs within the polymer.  This differs with previous studies which have 
focused on avidin-biotin interactions to tether a derivatized form of GABA to 
surfaces228,229.  The synthesis scheme allowed neurotransmitter motifs and polymer 
backbones to be varied.  The scheme also permits the ability to synthesize a variety of 
polymers, with the potential to study the effects of 2 or more neurotransmitters, polymer 
degradation, or mechanical properties that can be affected by the neurotransmitter motifs 
and polymer backbone.  This study is the first to demonstrate that neurite sprouting in 
vitro of DRG is affected in a biphasic manner by the concentration of the acetylcholine 
motifs presented by a polymer.  This subtle distinction suggests that maximizing the 
amount of chemical cues do not necessarily lead to maximized neurite growth.  By 
fabricating a microporous scaffold with channels from poly(glycerol sebacate), the effect 
of presenting biochemical and physical cues may be investigated in peripheral nerve 
injury models.      
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5.2  Potential and Limitations of Acetylcholine-based Polymers  
 It is yet unknown whether the acetylcholine-based polymers interact with the 
neurotransmitter’s receptors.  Incorporating aminoethyl acetate and leucine ethyl ester in 
the polymer may have affected surface chemistry or molecular topology, thereby 
influencing neurite sprouting.  The concentration of leucine ethyl ester, though it has no 
known effects on neurite sprouting, may also play a role in neurite growth.  Instead of 
leucine ethyl ester, other single amino acids with no known effects on sprouting, such as 
isoleucine, alanine, or asparagine, could also be used to investigate the effect of 
acetylcholine motifs in the polymer.  If these alternatives all show the same trend as what 
is observed in this study, then it is likely that the acetylcholine motif and not leucine ethyl 
ester is the bioactive moiety of the polymer.  While the antagonist binding studies suggest 
acetylcholine receptors are involved neurite sprouting, further assessments using 
electrophysiological recordings and molecular assays are needed to determine this. 
The concentration dependence of neurite sprouting observed on the acetylcholine-
based polymers could be caused by changes in protein adsorption pattern on the 
materials' surface.  No serum was added to the DRG culture and NGF was the only 
protein added to the system.  Cells may secrete their own proteins during culture, and 
their adsorption on the polymer can depend on surface chemistry and morphology.  
Different materials will likely yield different adsorption patterns and different protein 
configurations.  Protein adsorption may be investigated by methods such as ellipsometry, 
atomic force microscopy, or fluorescence spectroscopy, but these methods do not indicate 
conformation of the adsorbed proteins.  More sophisticated tools are required in addition 
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to these conventional techniques, as it is currently difficult to assess the protein 
configurations as they exist on the material surface within cell culture media. 
If the acetylcholine motifs interact with the receptors, these interactions could be 
used to elicit changes in electrical activity, extracellular matrix production, and cell cycle 
progression.  These changes can impact cells of the nervous system, as well as immune277 
and inflammatory cells278,279 that express acetylcholine receptors.  Given the potential 
interactions with acetylcholine receptors, the possibilities of using the acetylcholine-
based polymers will be discussed below.  
Activation of the acetylcholine receptor can modulate the cell’s electrical activity 
through the influx of calcium through voltage-gated calcium channels or the release of 
intracellular calcium stores.  These electrical changes through calcium transients play a 
role in growth cone turning163 and dendrite growth164,165.  Influx of calcium stimulates 
lamellipodia formation and axonal branching in cerebral cortex neurons167.  Calcium 
transients also play a role in inducing axon branching in cortical neurons by targeting the 
calcium/calmodulin-dependent protein kinase II164.  Electric field-induced membrane 
depolarization can similarly cause neurite initiation and elongation166,167.   
Depolarization may also convert the repulsive effect of soluble myelin-associated 
glyocoprotein to a growth-cone attractive molecule, which has been shown in frog 
neurons168.  Myelin-associated glycoprotein is a key inhibitory component that prevents 
axon regeneration after spinal cord injury.  By depolarizing the neurons with a potassium 
ion solution, higher intracellular calcium levels could be obtained, which then mediated 
attractive turning toward myelin-associated glycoprotein280.  If the acetylcholine-based 
polymer can modulate neurons’ depolarizations, it may be useful for inducing neurite 
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initiation and elongation, as well as promiting growth even in the presence of growth-
inhibitory cues.   
 Acetylcholine motifs on polymers may affect nerve regeneration through 
interactions with glial cells, since Schwann cells248, astrocytes245, and oligodendrocytes249 
express acetylcholine receptors.  Activating these receptors on glial cells can increase the 
proliferation of cortical astrocytes245 and oligodendrocyte progenitors281, though the 
mechanism is not fully understood.  If the same effect is seen with use of the 
acetylcholine-based polymers, the mitogenic effect of muscarinic receptor activation may 
be detrimental in repairing spinal cord injury since reactive astrocytes and 
oligodendrocytes are responsible for secreting growth-inhibitory proteins.  It is unknown 
whether the acetylcholine-based polymers will affect the production of chondroitin 
sulfate proteoglycans or myelin associated inhibitors.   
Though astrocytes produce the glial scar and chondroitin sulfate proteoglycans 
after central nerve injury, stimulating their acetylcholine receptors could induce neurite 
formation and modulate extracellular matrix production.  Astrocytes that have been 
stimulated with carbachol (an acetylcholine agonist) are capable of inducing 
neuritogenesis in hippocampal neurons282.  Carbachol stimulation induced astrocytes to 
produce and release fibronectin, laminin-1, and plasminogen activator inhibitor-1.  If the 
acetylcholine-based polymers are able to similarly induce extracellular matrix production 
and neuritogenesis, one could take advantage of the astrocytes’ presence at the injury site.  
Plasminogen activator inhibitor-1 inhibits the activity of plasminogen activators that are 
responsible for the formation of plasmin, a proteolytic enzyme that degrades many 
components of the extracellular matrix including laminin and fibronectin.  Plasminogen 
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activator inhibitor-1 has also been found to induce neurite outgrowth by directly 
phosphorylating Trk A receptors and activating ERK1/2 and c-Jun in PC12 cells282,283.  
Activation of the ERK1/2 pathway has also been implicated in neurite elongation of 
hippocampal neurons284, as well as protecting against arachidonic acid induced-apoptosis 
of spinal cord neurons222.  
This research presents one of the first studies to utilize covalent linkage of 
neurotransmitter motifs within polymers.  This approach contrasts to other materials 
utilized in nerve tissue engineering because acetylcholine-based polymers have the 
potential to directly affect the cell’s electrical activity by changing levels of calcium, a 
molecule that is ubiquitously used by cells in controlling a variety of cell processes.  
Activation of the acetycholine receptor mobilizes calcium signals, which can activate or 
deactivate calcium-sensitive processes (Table 5.1)285.  Neurons can respond to calcium 
signals by triggering exocytosis of neurotransmitters or inducing entry of calcium, which 
has numerous targets including: adenylyl cyclase I or II that control cyclic AMP 
production, proline-rich tyrosine kinase, mitogen-activated protein kinase, 
calcium/calmodulin-dependent kinase II, and calmodulin-calcineurin.   
Potential interactions between the acetylcholine motifs and nicotinic and 
muscarinic receptors on neurons and glia could mediate changes in calcium levels.  
Calcium’s regulatory role in a multitude of processes can have associated advantages and 
disadvantages.  This property could provide multiple targets of intervention for directing 
cell behavior, while competing effects may also exist between processes.  Figure 5.1 
illustrates calcium’s role in signalling pathways285 that have been implicated in nerve 
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regeneration.  The following paragraphs provide examples on how the polymer could 
potentially affect regeneration via calcium levels.   
Table 5.1.  Calcium-sensitive processes that affect cell behaviors that may play a 
role in nerve regeneration285. 
Calcium-sensitive process Cell behavior affected 
Troponin C  
Calmodulin activation of myosin-light 
chain kinase 
Contraction 
Ca2+/calmodulin-dependent protein kinase 
Transcription factors 
Learning and Memory 
Adenylyl cyclase 
Cyclic AMP phosphodiesterase 
Nitric oxide synthase 
Protein kinase C 
Proline-rich kinase 2 
Inositol-1,4,5-trisphosphate 
Cross-talk with other signaling pathways 
Ion channels Membrane excitability, Secretion 
Synaptotagmin Secretion 
Mitochondrial enzymes ATP synthesis, Steroid Synthesis 
Caspases Apoptosis 
 
  Figure 5.1.  Calcium interacts with: 1) cAMP; 2) Nitric oxide synthase; 3) 
phosphatidylinositol-3-OH kinase; 4) PLC; and 5) mitogen-activated protein 
kinase285. 
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 The polymer may increase calcium levels, which subsequently could increase 
cyclic adenosine monophosphate (cAMP) levels to facilitate nerve regeneration.  
Adenylyl cyclase can be activated by calcium to increase cAMP production.  Elevation of 
cyclic AMP levels may be particularly useful in regenerating the spinal cord by 
overcoming inhibition of myelin, promoting neuronal survival, and encouraging axonal 
extension beyond the spinal cord lesion.   
Transversing the injury site is a major challenge in regenerating the spinal cord; 
the presence of inhibitory proteins and the glial scar prevent growth across this boundary.  
Microinjecting a membrane-permeable analog of cyclic AMP increased regrowth of 
sensory neurons into the spinal cord lesion and could overcome myelin in vitro286.  
Elevating cAMP levels also prolong the survival of spinal motor neurons in culture, in a 
distinct manner from the addition of growth factors.  Spinal motor neurons cultured in the 
presence of multiple growth factors of BDNF, CNTF, FGF, GDNF, and HGF only 
transiently promoted survival, and most cells had died after 7 days in culture287.  In 
contrast, the majority of neurons cultured with cAMP survived in the same period and 
could do so even at low density.  Growth factors and cAMP could synergistically prolong 
survival287 as well as improve regeneration beyond the spinal cord lesion288.  
Furthermore, increasing cAMP levels can also increase expression of trk B (BDNF 
receptor)289, which can increase neurons’ sensitivity to the growth factor.    
 Another effect of calcium activation is to increase nitric oxide synthase (NOS), 
which can affect levels of nitric oxide, a mediator of inflammation and thrombosis.   
Following spinal cord injury, neuronal NOS in spinal cord cells is up-regulated290.  High 
levels of NOS are neurotoxic to spinal cord cells, and there is evidence in peripheral 
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nerve injury models that inhibiting NOS enhances myelination and survival of axons291.  
Mice with sciatic nerve injury that were treated with NOS inhibitors exhibited 
electrophysiological recovery earlier and had larger, myelinated fibers than control mice.  
Inflammation may damage cells but can also promote regeneration292-294; inflammation 
may be controlled by NOS levels according to calcium activation of the cell.  The 
potential upregulation of NOS via calcium-signalling events and corresponding increase 
the inflammatory response should be balanced against the potential anti-inflammatory 
effects that could also be mediated through acetylcholine receptors.  Macrophages 
express nicotinic278 and muscarinic279 acetylcholine receptors.  Nicotinic receptor 
activation inhibits the release of tumor necrosis factor by macrophages278 by supressing 
phosphorylation of I-kappa B and inhibiting the transcriptional activity of nuclear factor-
kappa B295.                
 Acetylcholine motifs have the potential to activate the receptor, which could 
induce changes in calcium levels that play a role in mediating cAMP and NOS levels.  In 
addition, the calcium transients could also activate the mitogen-activated protein kinase 
(MAPK) signalling pathway.  The ERK1/2 and c-Jun MAPK pathways have been 
implicated in neurite elongation282-284 following stimulation of the acetylcholine receptors 
of astrocytes and hippocampal neurons.  Growth factors, such as NGF, BDNF, and 
GDNF also activate MAPK296-298.  The acetylcholine-based polymers may exert their 
effects through the MAPK pathways, in addition to mediating cAMP and NOS. 
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Figure 5.2.  Signalling events following acetylcholine receptor activation299.  
Activating nicotinic acetylcholine receptor (nAchR) mobilizes calcium transients, which 
can modulate cAMP levels in the cell.  There are two subtypes of muscarinic 
acetylcholine receptors (mAchR).  m1, m3, and m5 mAchRs are associated with 
activating phospholipase C (PLC), while m2 and m4 mAchRs inhibit adenylyl cyclase 
activity.  PLA: phospholipase A, PLD: phospholipase D, PKC: protein kinase C, nNOS: 
neuronal nitric oxide synthase, IP3: inositol triphosphate, EGFR: epidermal growth factor 
receptor. ‘?’ indicates that studies suggest PLD mediates these events. 
 
 Activation of acetylcholine receptors may lead to downstream signalling events 
that ultimately could affect cell processes, including gene transcription, cytoskeletal 
dynamics, growth, and secretion242,299.  Figure 5.2 summarizes signalling pathways that 
may become involved, depending on whether nicotinic or muscarinic acetylcholine 
receptors are activated.  To assess whether acetylcholine-based polymers activate either 
of the two muscarinic receptor subtypes, measurement of downstream effectors can be 
performed.   
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Activation of phospholipase C catalyzes inositol triphosphate and diacylglycerol 
to form; this cascade mobilizes intracellular calcium, activates protein kinase C, and 
affects cell growth.  Inositol triphosphate production in response to stimulation with 
acetylcholine motifs can be performed, with and without the presence of subtype 
selective agonists that will block m1, m3, and m5 receptors.  Changes in inositol 
triphosphate levels would likely elicit corresponding changes on the downstream 
effectors.   
Transactivation of the epidermal growth factor receptor (EGFR) is another 
mechanism potentially activated by acetylcholine motifs.  Activation of muscarinic 
acetylcholine receptors activates the extracellular activity of a transmembrane 
metalloproteinase, which processes the EGFR and activates it.  Measuring 
metalloproteinase activity of the cell in response to exposure to the acetylcholine motif 
could be used to indicate this pathway’s involvement.  Selective antagonist to nicotinic 
receptors is not expected affect this activity.  
 
5.3 Evaluation of materials for nerve regeneration 
Nerve repair is likely to be a complex process, involving multiple cell 
interactions.  While the main interest is usually to assess how materials may promote 
growth, inflammatory and immune responses to the material are also very relevant and 
could determine the materials’ effectiveness in vivo.  Implantion of the materials in the 
body often involve protein adsorption and desorption, blood-material interactions, acute 
inflammation, and can further progress to chronic inflammation, granulation tissue 
development, foreign body reaction, and fibrosis/fibrous capsule development300.  
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Numerous proteins (such as those involved in the coagulation pathway) and non-neural 
cells (i.e. platelets, macrophages, leukocytes) are present and can interact with the 
materials’ surface.  Furthermore, the procedure of implanting scaffolds into the injury site 
could heighten the acute inflammatory response, since the implantation procedure would 
be invasive and likely damage existing vasculature.  In the case of implanting 
acetylcholine-based polymers for nerve regeneration, the deposition of proteins and cells 
could sufficiently obscure neurons or glia from interacting with the acetylcholine motif.  
Degradation product of the acetylcholine-based polymer into sebacic acid and a 
component containing the acetylcholine motif (see Section 3.4) could release the 
‘tentative active product’ into the site, with the potential to stimulate the neurons and glia 
in soluble form. 
Non-neural cells may also respond to acetylcholine motifs, which could affect 
their roles in the inflammation and immune responses.  As outlined in Section 5.1, 
macrophages express the acetylcholine receptor278,279, which when activated, can inhibit 
the release of tumor necrosis factor278.  Stimulating nicotinic acetylcholine receptors in 
vitro in mice-derived macrophages also caused increase proliferation of macrophages279.  
Potential activation of nicotinic receptors by the acetylcholine motif may quicken the 
formation of foreign body giant cells, since fusion of macrophages is involved in this 
process.   
Leukocytes, which are involved in the chronic inflammatory response and 
immune response to materials, also express muscarinic acetylcholine receptors301.  
Immunologic stimulation of T- and B- lymphocytes can lead to up-regulation of 
muscarinic receptors on their surfaces277, though it is unclear whether their activation 
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induces calcium transients302,303.  Leukocytes also play roles in thrombosis, acute 
inflammatory response, and foreign body giant cell formation.  It would be of interest if 
acetylcholine receptor activation of these cells plays a role in these responses. 
Evaluation of biomaterials in treating nerve injury mostly has focused on neuronal 
responses in vitro, quantification of the regenerated axon’s properties, or functional 
recovery that is assessed through behavioral testing.  There is no standard method or 
animal model to assess regeneration efficiency, making it difficult to identify effective 
strategies.  Several methods have been used for measuring neurite length alone, and many 
more exist for quantifying the extent of regeneration through a scaffold.  A method has 
been developed to assess functional recovery after spinal cord injury in rodents304, but it 
is not always utilized.  Because there is no universal test to assess functional recovery, 
distinctions and advantages associated with various treatment are difficult to determine.  
Additionally, there is no standard animal model for nerve injury.  Different 
experimental treatments studying their effects on nerve regeneration have been 
investigated in mice, rats, humans, and other animals.  Any resulting nerve regeneration 
may be dependent on variations between the recovery abilities of the animals and not 
wholly on the treatment.  Although it may be difficult to determine them at first, creating 
standard protocols and evaluation techniques will be of great value to the field of nerve 
regeneration.  The ability to compare nerve regeneration among the different materials 
that are used could give insights on effective approaches. 
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